 |
|
|
|
| Selected Reading |
 AAP Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2010-2011. (Policy statement) Pediatrics 2010 Oct;126(4):816-26 [Abstract]
AAP Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics 2011 (published online Sep 2) [Abstract]
AAP. Recommendation for mandatory influenza immunization of all health care personnel. (Policy statement) Pediatrics 2010 Oct;126(4):809-15 [Abstract]
Aballea S, De Juanes JR, Barbieri M, et al. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine 2007 Sep 28;25(39-40):6900-10 [Abstract]
Abed Y, Baz M, Boivin G. A novel neuraminidase deletion conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. J Infect Dis 2009 Jan 15;199(2):180-3 [Abstract]
Abed Y, Goyette N, Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother 2005 Feb;49(2):556-9 [Abstract]
Ablah E, Konda K, Tinius A, et al. Influenza vaccine coverage and presenteeism in Sedgwick County, Kansas. Am J Infect Control 2008 Oct;36(8):588-91 [Abstract]
Abramson JS, Neuzil KM, Tamblyn SE. Annual universal influenza vaccination: ready or not? Clin Infect Dis 2006 Jan 1;42(1):132-5 [Full text]
Acosta EP, Jester P, Gal P, et al. Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis 2010 Aug 15;202(4):563-6 [Abstract]
Acosta EP, Kimberlin DW. Determination of appropriate dosing of influenza drugs in pediatric patients. Clin Med Ther 2010 Nov;88(5):704-7 [Full text]
Adams B, McHardy AC. The impact of seasonal and year-round transmission regimes on the evolution of influenza A virus. Proc R Soc B 2010 Aug 7;278(1716):2249-56 [Abstract]
Adar Y, Singer Y, Levi R, et al. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 2009 Mar 26;27(15):2099-107 [Abstract]
Aebi T, Weisser M, Bucher E, et al. Co-infection of influenza B and Streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis 2010 Oct 27;10(1):388 [Abstract]
Aggarwal K, Jing F, Maranga L, et al. Bioprocess optimization for cell culture based influenza vaccine production. Vaccine 2011 Apr 12;29(17):3320-8 [Abstract]
Aguirre E, Papenburg J, Ouakki M, et al. Comparison of pandemic and seasonal influenza in the pediatric emergency department. Pediatr Infect Dis J 2011 Aug;30(8):633-9 [Abstract]
Aiello AE, Murray GF, Perez V, et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 2010 Feb 15;201(4):491-8 [Abstract]
Aiello AE, Perez V, Coulborn RM, et al. Facemasks, hand hygiene, and influenza among young adults: a randomized intervention trial. PLoS ONE 2012 Jan 25;7(1):e29744 [Full text]
Ajenjo MC, Woeltje KF, Babcock HM, et al. Influenza vaccination among healthcare workers: ten-year experience of a large healthcare organization. Infect Control Hosp Epidemiol 2010 Mar;31(3):233-40 [Abstract]
Akker ILVD, van Delden JJM, Verheij TJM, et al. Effects of a multi-faceted program to increase influenza vaccine uptake among health care workers in nursing homes: a cluster randomized controlled trial. Vaccine 2010 Jul 12;28(31):5086-92 [Abstract]
Alarcon JB, Hartley AW, Harvey NG, et al. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 2007 Apr;14(4):375-81 [Abstract]
Alborzi A, Aelami MH, Ziyaeyan M, et al. Viral etiology of acute respiratory infections among Iranian Hajj pilgrims, 2006. J Travel Med 2009 Jul-Aug;16(4);239-42 [Abstract]
Albright FS, Orlando P, Pavia AT, et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008 Jan 1;197(1):18-24 [Full text]
Aldridge JR Jr, Moseley CE, Boltz DA, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci 2009 Mar 31;106(13):5306-11 [Abstract]
Alexander ME, Kobes R. Effects of vaccination and population structure on influenza epidemic spread in the presence of two circulating strains. BMC Public Health 2011 Feb 25;11(1):S8 [Abstract]
Ali T, Scott N, Kallas W, et al. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). Clin Infect Dis 2004 Mar 1;38(5):760-2 [Abstract]
Alonso WJ, Viboud C, Simonsen L, et al. Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol 2007 Jun 15;165(12):1434-42 [Abstract]
Amaro RE, Swift RV, Votapka L, et al. Mechanism of 150-cavity formation in influenza neuraminidase. Nat Commun 2011 Jul 12;2(7):388 [Full text]
Ambrose CS, Luke C, Coelingh K. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Resp Viruses 2008 Dec 8;2(6):193-202 [Full text]
Ambrose CS, Yi TT, Walker RE, et al. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J 2008 Aug;27(8):744-8 [Abstract]
Amorij JP, Hinrichs WLJ, Frijlink HW, et al. Needle-free influenza vaccination. Lancet Infect Dis 2010 Oct;10(10):699-711 [Full text]
Amorij JP, Saluja V, Petersen AH, et al. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine 2007 Dec 17;25(52):8707-17 [Abstract]
Amour S, Voirin N, Regis C, et al. Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009). Vaccine 2012 Jan 20;30(5):821-4 [Abstract]
Anikeeva O, Braunack-Mayer A, Rogers W. Requiring influenza vaccination for health care workers. Am J Public Health 2009 Jan;99(1):24-9 [Abstract]
Ansaldi F, Bacilieri S, Durando P, et al. Cross-protection by MF59(TM)-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses. Vaccine 2008 Mar 17;26(12):1525-9 [Abstract]
Ansaldi F, Zancolli M, Paolo D, et al. Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates. Vaccine 2010 Jun 7;28(25):4123-9 [Full text]
Anton A, Marcos M, Codoner FM, et al. Influenza C virus surveillance during the first influenza A (H1N1) 2009 pandemic wave in Catalonia, Spain. Diagn Microbiol Infect Dis 2011 Apr;69(4):419-27 [Abstract]
APIC (Association for Professionals in Infection Control and Epidemiology). Influenza immunization of healthcare personnel. (Position Paper) Released Oct 9, 2008 [Full text]
Apisarnthanarak A, Puthavathana P, Kitphati R, et al. Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings. Infect Control Hosp Epidemiol 2008 Aug;29(8):777-80 [Abstract]
Apisarnthanarak A, Puthavathana P, Mundy LM. Risk factors and outcomes of influenza A (H3N2) pneumonia in an area where avian influenza (H5N1) is endemic. Infect Control Hosp Epidemiol 2007 Apr;28(4):479-82 [Abstract]
Arinaminpathy N, Grenfell B. Dynamics of glycoprotein charge in the evolutionary history of human influenza. PLoS ONE 2010 Dec 30;5(12):e15674 [Full text]
Arinaminpathy N, Ratmann O, Koelle K, et al. Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza. Proc Natl Acad Sci 2012 (published online Feb 7) [Abstract]
Arkema JM, Paget WJ, Meijer A, et al. Seasonal influenza beginning in Europe: report from EISS. Eurosurveillance Weekly 2007 Jan 25;12(1):E070125.3 [Full text]
Arkema JMS, Meijer A, Meerhoff TJ, et al. Epidemiological and virological assessment of influenza activity in Europe, during the 2006-2007 winter. Euro Surveill 2008 Aug 21;13(34):pi=18958 [Full text]
Arnoux S, Weinberger C, Gessner BD. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip--an activated split virion influenza vaccine--supports wider vaccine use. Vaccine 2007 Nov 7;25(45):7720-31 [Abstract]
Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ped Infect Dis J 2006 Oct;15(10):870-9 [Abstract]
Askarian M, Khazaeipour Z, McLaws ML. Influenza vaccination uptake among students and clinical staff of a university in Iran. Int J Infect Dis 2008 Jul;13(4):476-82 [Abstract]
Askarian M, Zhazaeipour, McLaws ML. Facilitators for influenza vaccination uptake in nurses at the Shiraz University of Medical Sciences. Public Health 2011 Aug;125(8):512-7 [Abstract]
Aspinall R, Del Giudice G, Effros RB, et al. Challenges for vaccination in the elderly. Immun Ageing 2007 Dec 11;4:9 [Abstract]
Athanasiou M, Baka A, Spala G, et al. Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011. Euro Surveill 2011 Nov 3;16(44):pii=20004 [Full text]
Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135-42 [Abstract]
Aucs P, Buchholz U, Haas W, et al. Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol 2005 Jun 21;2:6 [Full text]
Auewarakul P, Kositanont U, Sornsathapornkul P, et al. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007 Jan 8;25(4):659-63 [Abstract]
Baaten BJG, Clarke B, Hou S. Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in local pulmonary tissue. Vaccine 2010 Jun 7;28(25):4130-7 [Full text]
Babcock HM, Gemeinhart N, Jones M, et al. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis 2010 Feb 15;50(4):459-64 [Abstract]
Babcock HM, Merz LR, Dubberke ER, et al. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008 Oct;19(10):921-6 [Abstract]
Bahgat MM, Blazejewska P, Schughart K. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection. Virol J 2011 Jan 20;8:27 [Abstract]
Bahl J, Nelson MI, Chan KH, et al. Temporally structured metapopulation dynamics and persistence of influenza A H3N2 virus in humans. Proc Natl Acad Sci 2011 (published online Nov 14) [Abstract]
Baldo V, Baldovin T, Floreani A, et al. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 2007 May 16;25(20):3955-61 [Abstract]
Balicer RD, Huerta M, Levy Y, et al. Influenza outbreak control in confined settings. Emerg Infect Dis 2005 Apr;11(4):579-83 [Full text]
Banzhoff A, Pellegrini M, Del Giudice G, et al. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza Other Resp Viruses 2008 Dec 8;2(6):243-9 [Full text]
Bardenheier B, Shefer A, McKibben L, et al. Characteristics of long-term care facility residents associated with receipt of influenza and pneumococcal vaccinations. Infect Control Hosp Epidemiol 2004 Dec;25(11):946-54 [Abstract]
Barefoot BE, Sample CJ, Ramsbury EA. A vesicular stomatitis virus recombinant expressing influenza nucleoprotein induces CD8 T cell responses which enhance antibody mediated protection after lethal influenza challenge. Clin Vaccine Immunol 2009 Apr;16(4):488-98 [Abstract]
Barrett PN, Berezuk G, Fritsch S, et al. Efficacy, safety, and immunogenicity of a vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomized, placebo-controlled trial. Lancet 2011 Feb 26;377(9767):751-9 [Abstract]
Basta NE, Halloran ME, Matrajt L, et al. Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol 2008 Dec 15;168(12):1343-52 [Abstract]
Bastien N, Antonishyn NA, Brandt K, et al. Human infection with a triple-reassortant swine influenza A(H1N1) virus containing the hemagglutinin and neuraminidase genes of seasonal influenza virus. J Infect Dis 2010 Apr 15;201(8):1178-82 [Abstract]
Bastien N, Bowness D, Burton L, et al. Parotitis in a child infected with triple reassortant influenza A, Canada, 2007. J Clin Microbiol 2009 Jun;47(6):1896-8 [Abstract]
Bauer K, Richter M, Wutzler P, et al. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006. Antiviral Res 2009 Apr;82(1):34-41 [Abstract]
Baumbach JP, Mueller M, Smelser C, et al. Enhancement of influenza surveillance with aggregate rapid influenza test results: New Mexico, 2003-2007. Am J Public Health 2008 Oct;99 Suppl 2:S372-7 [Abstract]
Baxter R, Lee J, Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 2010 Jan 15;201(2):186-9 [Abstract]
Baxter R, Lewis N, Bakshi N, et al. Recurrent Guillain-Barre syndrome following vaccination. Clin Infect Dis 2012 (published online Jan 19) [Abstract]
Baxter R, Patriarca PA, Ensor K, et al. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to health adults 50-64 years of age. Vaccine 2011 Mar 9;29(12):2272-8 [Abstract]
Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010 Oct 21;28(45):7267-72 [Abstract]
Baz M, Abed Y, McDonald J, et al. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 2006 Dec 15;43(12):1555-61 [Abstract]
Baz M, Abed Y, Simon P, et al. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis 2010 Mar 1;201(5):740-5 [Abstract]
Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One 2011 Dec;6(12):329249 [Full text]
Beck ET, Jurgens LA, Kehl SC, et al. Development of a rapid automated influenza A, influenza B, and respiratory syncytial virus A/B multiplex real-time RT-PCR assay and its use during the 2009 H1N1 swine-origin influenza virus epidemic in Milwaukee, Wisconsin. J Molec Diagn 2010 Jan;12(1):74-81 [Abstract]
Beckett CG, Kosasih H, Ma'roef C, et al. Influenza surveillance in Indonesia: 1999-2003. Clin Infect Dis 2004 Aug 15;39(4):443-9 [Abstract]
Bedford T, Cobey S, Beerli P, et al. Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PloS Pathog 2010 May 27;6(5):e1000918 [Full text]
Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102 [Abstract]
Belongia EA, Coleman LA, Donahue JG. Effectiveness of influenza vaccination. (Letter) N Engl J Med 2007 Dec 27;357(26):2728-31 [Full text]
Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010 Sep 8;304(10):1091-8 [Abstract]
Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009 Jan 15;199(2):159-67 [Full text]
Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011 Sep 2;29(38):6558-63 [Abstract]
Belsche RB. Translational research on vaccines: influenza as an example. Clin Pharmacol Ther 2007 Dec;82(6):745-9 [Abstract]
Belser JA, Maines TR, Tumpey TM, et al. Influenza A virus transmission: contributing factors and clinical implications. Expert Rev Mol Med 2010 Dec 9;12:e39 [Abstract]
Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007 Feb 15;256(7):685-96 [Abstract]
Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000 Feb;136(2):168-75 [Abstract]
Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004 Nov 25;351(22):2286-94 [Full text]
Belshe RB, Newman FK, Wilkins K, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007 Sep 17;25(37-38):6755-63 [Abstract]
Belshe RB, Nichol KL, Black SB, et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Clin Infect Dis 2004 Oct 1;39(7):920-7 [Abstract]
Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010 Aug 14;28(suppl 4):D45-53 [Abstract]
Benet T, Regis C, Voirin N, et al. Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients. BMC Infect Dis 2012 Feb 1;12:30 [Abstract]
Benito-Fernandez J, Vazquez-Ronco M, Morteruel-Aizkuren E, et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Ped Infect Dis J 2006 Dec;25(12):1153-7 [Abstract]
Bennet KJ, Pumkam C, Probst JC. Rural-urban differences in the location of influenza vaccine administration. Vaccine 2011 Aug 11;29(35):5970-7 [Abstract]
Benowitz I, Esposito DB, Gracey KD, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010 Dec 15;51(12):1355-61 [Full text]
Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Medicine 2009 Apr 2;7:13 [Abstract]
Beran J, Wertzova V, Honegr K, et al. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis 2009 Jan 17;9:2 [Abstract]
Bergen R, Black S, Shinefield H, et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004 Feb;23(2):138-44 [Abstract]
Bernard H, Fischer R, Mikolajczyk RT, et al. Nurses' contacts and potential for infectious disease transmission. Emerg Infect Dis 2009 Sep;15(9):1438-44 [Full text]
Berthoud TK, Hamill M, Lillie PJ, et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 2011 Jan 1;52(1):1-7 [Full text]
Besselaar TG, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. (Letter) Emerg Infect Dis 2008 Nov;14(11):1809-10 [Full text]
Beutels P, Scuffham PA, MacIntyre CR. Funding of drugs: do vaccines warrant a different approach? (Personal view) Lancet Infect Dis 2008 Nov;8(11):727-33 [Abstract]
Beyer WEP, Nauta JJP, Palache AM, et al. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis. Vaccine 2011 Aug 5;29(34):5785-92 [Abstract]
Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005 Dec 15;353(24):2559-67 [Abstract]
Bhat-Schelbert K, Lin CJ, Matambanadzo A, et al. Barriers to and facilitators of child influenza vaccine: perspectives from parents, teens, marketing and healthcare professionals. Vaccine 2012 (published online Jan 31) [Abstract]
Biere B, Schweiger B, Nitsche A. Influenza A H1N1 diagnostics: the first, the fastest, and the most reliable. Lancet Infect Dis 2009 Dec;9(12):721-2 [Abstract]
Bin-Reza F, Chavarrias VL, Nicoll A, et al. The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence. Influenza Other Respi Viruses 2011 (published online Dec 21) [Abstract]
Bischoff WE, Reid T, Russell GB, et al. Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of N95 respirators, surgical masks, and eye protection in humans. J Infect Dis 2011 Jul 15;204(2):193-9 [Abstract]
Bishburg E, Shah M, Mathis AS. Influenza vaccination among medical residents in a teaching hospital. Infect Control Hosp Epidemiol 2008 Jan;29(1):89-91 [Abstract]
Blachere FM, Lindsley WG, Pearce TA, et al. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 2009 Feb 1;48(4):438-40 [Abstract]
Black S, Cioppa, GD, Malfroot A, et al. Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis. Vaccine 2010 Oct 21;28(45):7331-6 [Abstract]
Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011 Dec;30(12):1081-5 [Abstract]
Blackburne BP, Hay AJ, Goldstein RA. Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog 2008 May 2;4(5):e1000058 [Full text]
Blanchard-Rohner G, Siegrist CA. Vaccination during pregnancy to protect infants against influenza: why and why not? Vaccine 2011 Oct 6;29(43):7542-50 [Abstract]
Blank DL, Bodansky DMS, Forbes A, et al. Influenza vaccination of future healthcare workers: a cross-sectional study of uptake, knowledge and attitudes. Vaccine 2010 Jun 23;28(29):4668-72 [Full text]
Blank PR, Freiburghaus AU, Schwenkglenks M, et al. Trends in influenza vaccination coverage rates in the United Kingdom over six seasons from 2001-2 to 2006-7. Eurosurveill 2008 Oct 23;13(43):3 [Full text]
Blank PR, Schwenkglenks M, Szucs TD. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Infection 2009 Oct;37(5):390-400 [Abstract]
Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008 Aug 1;8:272 [Abstract - with link to full text]
Block SL, Yi T, Sheldon E, et al. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults. Vaccine 2011 Nov 21;29(50):9391-7 [Abstract]
Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010 Jun 4;328(5983):1272-5 [Abstract]
Blyth CC, Currie AJ, Wiertsema SP, et al. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine 2011 Jul 18;29(32):5107-13 [Abstract]
Blyth CC, Kelso A, McPhie KA, et al. The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. Euro Surveill 2010 Aug 5;15(31):pii=19631 [Full text]
Blyth CC, Markus TY, Effier PV, et al. Ensuring safety of the 2011 trivalent influenza vaccine in young children. (Letter) Med J Aust 2011 (published online Jun 6) [Abstract]
Bodewes R, Fraaij PLA, Geelhoed-Mieras MM, et al. Annual vaccination against influenza hampers development of virus-specific CD8+ T cell immunity in children. J Virol 2011 Nov;85(22):11995-2000 [Abstract]
Bodewes R, Kreijtz JH, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis 2009 Dec;9(12):784-8. [Abstract]
Bodewes R, Kreijtz JHCM, Geelhoed-Mieras MM, et al. Vaccination against seasonal influenza A/H3N2 reduces the induction of heterosubtypic immunity against influenza A/H5N1 in ferrets. J Virol 2011 Mar;85(6):2695-702 [Abstract]
Bodewes R, Kreijtz JHCM, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? (Commentary) Lancet Infect Dis 2009 Dec;9(12):784-8 [Abstract]
Bodor M, Montalvo E. Vaccination-related shoulder dysfunction. Vaccine 2007 Jan 8;25(4):585-7 [Abstract]
Boesteanu AC, Babu NS, Wheatley M, et al. Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus. Vaccine 2010 Dec 16;29(2):314-22 [Abstract]
Boggild AK, Yuan L, Low DE, et al. The impact of influenza on the Canadian first nations. Can J Public Health 2011 Sep-Oct;102(5):345-8 [Abstract]
Bohmer MM, Walter D, Muters S, et al. Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: results from a national health update survey. Vaccine 2011 Jun 15;29(27);4492-8 [Abstract]
Bolotin S, Pebody R, White PJ, et al. A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalized cases in the post-pandemic period. PLoS ONE 2012 Jan 23;7(1):e30279 [Full text]
Bommakanti G, Citron MP, Hepler RW, et al. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc Natl Acad Sci 2010 Aug 3;107(31):13701-6 [Abstract]
Boni MF, de Jong MD, van Doorn HR, et al. Guidelines for identifying homologous recombination events in influenza A virus. PLoS ONE 2010 May 3;5(5):e10434 [Full text]
Booy R, El Bashir H, Rashid H, et al. Influenza and meningococcal disease: lessons for travellers and government from 2 epidemic diseases. Trav Med Infect Dis 2008 Jul;7(4):253-6 [Abstract]
Borkow G, Zhou SS, Page T, et al. A novel anti-influenza copper oxide containing respiratory face mask. PLoS ONE 2010 Jun 25;5(6):e11295 [Full text]
Borlaug G, Newman A, Pfister J, et al. Factors that influenced rates of influenza vaccination among employees of Wisconsin acute care hospitals and nursing homes during the 2005-2006 influenza season. Infect Control Hosp Epidemiol 2007 Dec;28(12):1398-1400 [Abstract]
Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31 [Abstract]
Bountouri M, Fragkiadaki E, Ntafis V, et al. Phylogenetic and molecular characterization of equine H3N8 influenza viruses from Greece (2003 and 2007): evidence for reassortment between evolutionary lineages. Virol J 2011 Jul 14;8:350 [Abstract]
Bourgeois FT, Valim C, McAdam AJ, et al. Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics 2009 Dec;124(6):e1072-80 [Abstract]
Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses transmit efficiently among guinea pigs by direct contact but not by aerosol. J Virol 2008 Oct;82(20):10052-8 [Abstract]
Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006 - a complete genome study. Virol J 2008 Mar 7;5(1):40 [Abstract]
Brammer L, Budd A, Cox N. Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Resp Viruses 2009 Mar;3(2):51-8 [Abstract]
Brandt C, Rebenau HF, Bornmann S, et al. The impact of the 2009 influenza A(H1N1) pandemic on attitudes of healthcare workers toward seasonal influenza vaccination 2010/11. Euro Surveill 2011 Apr 28;16(17):pii=19854 [Full text]
Brankston G, Gitterman L, Hirji A, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007 Apr;7(4):257-65 [Abstract]
Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7 [Full text]
Brewer NT, Hallman WK. Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis 2006 Dec 1;43(11):1379-86 [Abstract]
Bright RA, Carter DM, Daniluk S, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007 May 10;25(19):3781-8 [Abstract]
Bright RA, Medina M, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005 Oct 1;366(9492):1175-81 [Abstract]
Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 Feb 22;295(8):891-4 [Abstract]
Brooks WA, Terebuh P, Bridges C, et al. Influenza A and B infection in children in urban slum, Bangladesh. (Letter) Emerg Infect Dis 2007 Oct;13(10):1507-8 [Full text]
Broor S, Krishnan A, Roy DS, et al. Dynamic patterns of circulating seasonal and pandemic A(H1N1)pdm09 influenza viruses from 2007-2010 in and around Delhi, India. PLoS ONE 2012 Jan 3;7(1):e29129 [Full text]
Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004;61(8):774-80 [Abstract]
Brown LE. The role of adjuvants in vaccines for seasonal and pandemic influenza. Vaccine 2010 Nov 23;28(50):8043-5 [Abstract]
Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 2005 Oct 1;162(7):686-93 [Abstract]
Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10):e401 [Full text]
Bryant KA, Stover B, Cain L, et al. Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol 2004 Dec;25(11):912-7 [Abstract]
Bucher SJ, Brickner PW, Vincent RL. Influenzalike illness among homeless persons. (Letter) Emerg Infect Dis 2006 Jul;12(7):1162-3 [Full text]
Buchholz U, Brockmann S, Duwe S, et al. Household transmissibility and other characteristics of seasonal oseltamivir-resistant influenza A(H1N1) viruses, Germany, 2007-8. Euro Surveill 2010 Feb 11;15(6):4 [Full text]
Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51 [Abstract]
Bulimo WD, Garner JL, Schnabel DC, et al. Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya. Influenza Other Resp Viruses 2008 Jun 28;2(3):107-13 [Abstract]
Bundy DG, Strouse JJ, Casella JF, et al. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics 2010 Feb;125(2):234-43 [Abstract]
Burbacher TM, Shen DD, Liberato N, et al. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005 Apr 21;113:1015-21 [Full text]
Burch J, Corbett M, Stock C, et al. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis 2009 Sep;9(9):537-45 [Abstract]
Byarugaba DK, Ducatez MF, Erima B, et al. Molecular epidemiology of influenza A/H3N2 viruses circulating in Uganda. PLoS ONE 2011 Nov 21;6(11):e27803 [Full text]
Cabello J, Das K, Trick WE, et al. House staff attitudes about influenza vaccination after participation in a clinical trial to improve vaccination of hospital patients. Infect Control Hosp Epidemiol 2008 Feb;29(2):174-6 [Abstract]
Cadena J, Prigmore T, Bowling J, et al. Improving influenza vaccination of healthare workers by means of quality improvement tools. Infect Control Hosp Epidemiol 2011 Jun;32(6):616-8 [Full text]
Cady SD, Schmidt-Rohr K, Wang J, et al. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 2010 Feb 4;463(7281):689-92 [Abstract]
Cai S, Feng Z, Fennell ML, et al. Despite small improvement, black nursing home residents remain less likely than whites to receive flu vaccine. Health Aff 2011 Oct;30(10):1939-46 [Abstract]
Calistri A, Salata C, Cosentino M, et al. Report of two cases of influenza A/H1N1v and B co-infection during the 2010/2011 epidemics in the Italian Veneto region. Virol J 2011 Nov 3;8:502 [Abstract]
Callaghan WM, Chu SY, Jamieson DJ. Deaths from seasonal influenza among women in the United States, 1998-2005. Obstet Gynecol 2010 May;115(5):919-23 [Abstract]
Camilloni B, Neri M, Lepri E, et al. An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. Vaccine 2010 Nov 3;28(47):7536-41 [Full text]
Campitelli MA, Rosella LC, Stukel TA, et al. Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine 2010 Dec 16;29(2):240-6 [Abstract]
Canini L, Andreoletti L, Ferrari P, et al. Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS ONE 2010 Nov 17;5(11):e13998 [Full text]
Caplan A. Time to mandate influenza vaccination in health-care workers. (Perspective) Lancet 2011 Jul 23;378(9788):310-1 [Full text]
Capua I, Cattoli G. One Flu for One Health. (Letter) Emerg Infect Dis 2010 Apr;16(4):719 [Full text]
Carcione D, Giele C, Dowse GK, et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis 2010 Sep;16(9):1388-95 [Full text]
Carey MA, Bradbury JA, Rebolloso YD, et al. Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLoS ONE 2010 Jul 15;5(7):e11610 [Full text]
Carlson SJ, Durrheim DN, Dalton CB. Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007-2009. Vaccine 2010 Oct 4;28(42):6809-10 [Abstract]
Carpenter LR, Lott J, Lawson BM, et al. Mass distribution of free, intranasally administered influenza vaccine in a public school system. Pediatrics 2007 Jul;120(1):e172-8 [Abstract]
Carr S, Allison KJ, de Velde LAV, et al. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis 2011 (published online Sep 23) [Abstract]
Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007 Sep 28;25(39-40):6852-62 [Abstract]
Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008 Apr 1;167(7):775-85 [Full text]
Casalegno JS, Frobert E, Escuret V, et al. Beyond the influenza-like illness surveillance: the need for real-time virological data. Euro Surveill 2011 Jan 6;16(1):pii=19756 [Full text]
Casscells SW, Granger E, Kress AM, et al. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes 2009 Mar;2(2):108-15 [Abstract]
Cassone A, Rappuoli R. Universal vaccines: shifting to one for many. (Perspective) mBio 2010 May 18;1(1):e00042-10 [Full text]
Castilla J, Martinez-Artola V, Salcedo E, et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012 Jan;30(2):195-200 [Abstract]
Castilla J, Moran J, Martinez-Artola V, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1) 2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveill 2011 Feb 17;16(7):pii=19799 [Full text]
CDC. 2009 H1N1 and seasonal flu and African American communities: questions and answers. Feb 17, 2010 [Full text]
CDC. 2009 H1N1 and seasonal influenza and Hispanic communities: questions and answers. Feb 16, 2010 [Full text]
CDC. 2009 H1N1 influenza vaccine dose spacing and administration with seasonal influenza and other vaccines. Nov 20, 2009 [Full text]
CDC. 2009-2010 Influenza season triage algorithm for children (< 18 years) with influenza-like illness. Oct 16, 2009 [Chart]
CDC. 2010-2011 seasonal influenza (flu) vaccine safety (Q&A). Oct 12, 2010 [Web page]
CDC. Antiviral safety information. Dec 24, 2009 (updated regularly) [Full text]
CDC. Assessment of ESSENCE performance for influenza-like illness surveillance after an influenza outbreak--U.S. Air Force Academy, Colorado, 2009. MMWR 2011 Apr 8;60(13):406-9 [Full text]
CDC. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults: Colorado, 2003. MMWR 2004 Aug 13;53(31):707-10 [Full text]
CDC. CDC guidance for responses to influenza for institutions of higher education during the 2009-2010 academic year. Feb 22, 2010 [Full text]
CDC. CDC guidance on helping child care and early childhood programs respond to influenza during the 2009-2010 influenza season. Feb 22, 2010 [Full text]
CDC. CDC guidelines for large-scale influenza vaccination clinic planning. Aug 4, 2010 [Full text]
CDC. CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005-2006 influenza season. CDC Health Alert. Jan 14, 2006 [Full text]
CDC. CDC statement on oseltamivir (Tamiflu) resistance and antiviral recommendations. Jan 9, 2009 [Full text]
CDC. Characteristics associated with seasonal influenza vaccination of preschool children--Oregon, 2006-2008. MMWR 2011 Jul 29;60(29):981-4 [Full text]
CDC. Destruction of influenza A (H2N2) proficiency testing samples; interim guidance for biosafety level 3-enhanced biocontainment for work with human influenza A (H2N2) viruses. May 3, 2005 [Full text]
CDC. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1)--United States, May-June 2009. MMWR 2009 Nov 13;58(44):1241-5 [Full text]
CDC. Estimated influenza vaccination coverage among adults and children--United States, September 1, 2004-January 31, 2005. MMWR 2005 April 1;54(12):304-7 [Full text]
CDC. Estimates of deaths associated with seasonal influenza--United States, 1976-2007. MMWR 2010 Aug 27;59(33):1057-62 [Full text]
CDC. Experiences with influenza-like illness and attitudes regarding influenza prevention: United States, 2003-04 influenza season. MMWR 2004 Dec 17;53(49):1156-8 [Full text]
CDC. Final estimates for 2009-10 seasonal influenza and influenza A (H1N1) 2009 monovalent vaccination coverage -- United States, August 2009 through May, 2010. Oct 7, 2010 [Full text]
CDC. Flu information for people with diabetes and caregivers of people with diabetes. Jan 6, 2010 [Full text]
CDC. Flu vaccine effectiveness: questions and answers for health professionals. Updated Oct 13, 2011 [Full text]
CDC. General questions and answers on thimerosal. Dec 15, 2009 [Full text]
CDC. Guidance for state and local public health officials and school administrators for school (K-12) responses to influenza during the 2009-2010 school year. Feb 22, 2010 [Full text]
CDC. Impact of seasonal influenza-related school closures on families--southeastern Kentucky, February 2008. MMWR 2009 Dec 25;58(50):1405-9 [Full text]
CDC. Infection control measures for preventing and controlling influenza transmission in long-term care facilities. Aug 1, 2009 [Full text]
CDC. Influenza and pneumococcal vaccination coverage among persons aged >/=65 Years--United States, 2004-2005. MMWR 2006 Oct 6;55(39):1065-8 [Full text]
CDC. Influenza and pneumonococcal vaccination coverage among persons aged >/=65 years with diabetes or asthma: United States, 2003. MMWR 2004 Nov 5;53(43):1007-12 [Full text]
CDC. Influenza round table: warning signs. Released Nov 5, 2009 [Video for consumers]
CDC. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged >/=65 years: United States, 1991-2002. MMWR 2004 Nov 5;53(43):1012-5 [Full text]
CDC. Influenza vaccination coverage among children aged 16 months - 18 years--eight immunization information system sentinel sites, United States, 2008-2009 influenza season. MMWR 2009 Oct 2;58(38):1059-62 [Full text]
CDC. Influenza vaccination coverage among children aged 6-23 months--United States, 2008-09 influenza season. Oct 6, 2010 [Full text]
CDC. Influenza vaccination coverage among children and adults--United States, 2008-09 influenza season. MMWR 2009 Oct 9;58(39):1091-5 [Full text]
CDC. Influenza vaccination coverage among health-care personnel--United States, 2010-11 influenza season. MMWR 2011 Aug 19;60(32):1073-7 [Full text]
CDC. Influenza vaccination coverage among pregnant women--United States, 2010-11 influenza season. MMWR 2011 Aug 19;60(32):1078-82 [Full text]
CDC. Influenza vaccination levels among persons aged >/=65 years and among persons aged 18-64 years with high-risk conditions: United States, 2003. MMWR 2005 Oct 21;54(41):1045-9 [Full text]
CDC. Influenza-associated pediatric deaths--United States, September 2010-August 2011. MMWR 2011 Sep 16;60(36):1233-8 [Full text]
CDC. Influenza-associated pediatric mortality and Staphylococcus aureus co-infection. (CDC Health Advisory) Jan 30, 2008 [Full text]
CDC. Influenza-associated pediatric mortality and the increase of Staphylococcus aureus co-infection. (CDC Health Advisory) May 9, 2007 [Full text]
CDC. Influenza-testing and antiviral-agent prescribing practices--Connecticut, Minnesota, New Mexico, and New York, 2006-07 influenza season. MMWR 2008 Jan 25;57(3):61-5 [Full text]
CDC. Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines--two counties, North Carolina, August 2009. MMWR 2009 Dec 25;58(50):1401-5 [Full text]
CDC. Interim guidance on the use of influenza antiviral agents during the 2010-2011 influenza season. Published online Nov 16, 2010 [Full text]
CDC. Interim recommendations for clinical use of influenza diagnostic tests during the 2009-10 influenza season. Sep 29, 2009 [Full text]
CDC. Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel--United States, August 2009-January 2010. MMWR 2010 Apr 2;59(12):357-62 [Full text]
CDC. Interim results: state-specific influenza vaccination coverage--United States, August 2010-February 2011. MMWR 2011 Jun 10;60(22):737-43 [Full text]
CDC. Interim results: state-specific seasonal influenza vaccination coverage--United States, August 2009-January 2010. MMWR 2010 Apr 30;59(16):477-84 [Full text]
CDC. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. MMWR 2008 Apr 18;57(15):393-8 [Full text]
CDC. Interventions to increase influenza vaccination of health-care workers. MMWR 2005 Mar 4;54(8):196-9 [Full text]
CDC. Licensure of a high-dose inactivated influenza vaccine for persons aged >=65 years (Fluzone High-Dose) and guidance for use--United States, 2010. MMWR 2010 Apr 30;59(16):485-6 [Full text]
CDC. Limited human-to-human transmission of novel influenza A (H3N2) virus--Iowa, November 2011. MMWR 2011 Nov 23;60(Dispatch):1-3 [Full text]
CDC. Monitoring influenza activity, including 2009 H1N1. (Q&A) May 28, 2010 [Full text]
CDC. Notice to readers: Expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2-4 years and other FluMist changes for the 2007-08 influenza season. MMWR 2007 Nov 23;56(46):1217-9 [Full text]
CDC. Place of influenza vaccination among adults--United States, 2010-11 influenza season. MMWR 2011 Jun 17;60(23):781-5 [Full text]
CDC. Preparing for the flu: a communication toolkit for institutions of higher education. Mar 25, 2010 [Full text]
CDC. Preventing the spread of influenza (the flu) in child care settings: guidance for administrators, care providers, and other staff. Posted Oct 2, 2007 [Full text]
CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011 Aug 26;60(33):1128-32 [Full text]
CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2009 Jul 24;58(Early Release):1-52 [Full text]
CDC. Q&A: Thimerosal and 2010-2011 seasonal flu vaccines. Oct 12, 2010 [Full text]
CDC. Questions & answers: Thimerosal and 2010-2011 seasonal flu vaccines. Oct 12, 2010 [Full text]
CDC. Questions & answers: vaccine effectiveness (How well does the influenza or 'flu' vaccine work?). Published online Jan 11, 2007 [Full text]
CDC. Rapid assessment of influenza vaccination coverage among HMO members: northern California influenza seasons, 2001-02 through 2004-05. MMWR 2005 Jul 15;54(27):676-8 [Full text]
CDC. Receipt of influenza vaccine during pregnancy among women With live births--Georgia and Rhode Island, 2004-2007. MMWR 2009 Sep 11;58(35):972-5 [Full text]
CDC. Recommendations for use of antiviral medications for the management of influenza in children and adolescents for the 2009-2010 Season: pediatric supplement for health care providers. Dec 24, 2009 [Full text]
CDC. Seasonal flu information for businesses & employees. Jul 26, 2011 [Web page]
CDC. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women--10 states, 2009-10 influenza season. MMWR 2010 Dec 3;59(47);1541-5 [Full text]
CDC. Seasonal influenza vaccination coverage among children aged 6 months-18 years--eight immunization information system sentinel sites, United States, 2009-10 influenza season. MMWR 2010 Oct 8;59(39):1266-9 [Full text]
CDC. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 2009 May 22;58(19):521-4 [Full text]
CDC. Severe influenza among children and young adults with neurologic and neurodevelopmental conditions--Ohio, 2011. MMWR 2012 Jan 6;60(51):1729-33 [Full text]
CDC. Severe morbidity and mortality associated with influenza in children and young adults: Michigan, 2003. MMWR 2003:52(35):837-40 [Full text]
CDC. State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season. MMWR 2008 Sep 26;57(38):1033-9 [Full text]
CDC. Surveillance for laboratory-confirmed, influenza-associated hospitalizations: Colorado, 2004-05 influenza season. MMWR 2005 Jun 3;54(21):535-7 [Full text]
CDC. Swine-origin influenza A (H3N2) virus infection in two children--Indiana and Pennsylvania, July-August 2011. MMWR 2011 Sep 2;60(Early release):1-4 [Full text]
CDC. Technical report for state and local public health officials and child care and early childhood providers on CDC guidance on helping child care and early childhood programs respond to influenza during the 2009-2010 influenza season. Feb 22, 2010 [Full text]
CDC. Technical report for state and local public health officials and school administrators on CDC guidance for school (K-12) responses to influenza during the 2009-2010 school year. Feb 22, 2010 [Full text]
CDC. Technical report on CDC guidance for responses to influenza for institutions of higher education during the 2009-2010 academic year. Feb 22, 2010 [Full text]
CDC. Tiered use of inactivated influenza vaccine in the event of a vaccine shortage. MMWR 2005 Aug 5;54(30):749-50 [Full text]
CDC. Update: Influenza A (H3N2)v transmission and guidelines--five states, 2011. MMWR 2011 Dec 23;60(Early Release):1-4 [Full text]
CDC. Update: influenza activity--United States and worldwide, May 22-September 3, 2011. MMWR 2011 Sep 16;60(36):1239-42 [Full text]
CDC. Update: influenza activity--United States, 2009-10 season. MMWR 2010 Jul 30;59(29):901-8 [Full text]
CDC. Update: influenza activity--United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR 2011 Jun 3;60(21):705-12 [Full text]
CDC. Update: influenza activity--United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. MMWR 2010 Apr 16;59(14):423-30 [Full text]
CDC. Update: influenza activity--United States, October 2-November 26, 2011. MMWR 2011 Dec 9;60(48):1646-9 [Full text]
CDC. Update: influenza activity--United States, October 3, 2010-February 5, 2011. MMWR 2011 Feb 18;60(06):175-81 [Full text]
CDC. Update: influenza activity--United States, October 3-December 11, 2010. MMWR 2010 Dec 24;59(50):1651-5 [Full text]
CDC. Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. MMWR 2009 Apr 17;58(14):369-74 [Full text]
CDC. Update: influenza activity--United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine. MMWR 2008 Apr 18;57(15):404-9 [Full text]
CDC. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Dec 7, 2009 [Full text]
CDC. Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. MMWR 2009 Apr 3;58(12):312 [Full text]
CDC. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2003 Sep 26:52(RR13):1 [Full text]
CDC/DHS. Guidance for businesses and employers to plan and respond to the 2009-2010 influenza season. Feb 22, 2010 [Full text]
Ceyhan M, Oncel EK, Badur S, et al. Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir) on 2010-2011 seasonal influenza viruses: an open phase IV study. Int J Infect Dis 2012 (published online Feb 10) [Abstract]
Chan MCW, Lee N, Chan PKS, et al. Seasonal influenza A virus in feces of hospitalized adults. Emerg Infect Dis 2011 Nov;17(11):2038-42 [Full text]
Chan RWY, Yuen KM, Yu WCL, et al. Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS ONE 2010 Jan 15;5(1):e8713 [Full text]
Chan TC, Hsiao CK, Lee CC, et al. The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly. PLoS ONE 2010 Jun 25;5(6):e11317 [Full text]
Chan TC, Hung IFN, Luk JKH, et al. Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: a one-year prospective cohort study. Vaccine 2011 Oct 13;29(44):7773-8 [Abstract]
Chang YS, van Hal SJ, Spencer PM, et al. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust 2010 Jan 18;192(2):90-3 [Full text]
Chao DL, Bloom JD, Kochin BF, et al. The global spread of drug-resistant influenza. J R Soc Interface 2011 (published online Aug 24) [Abstract]
Chapman GB, Li M, Colby H, et al. Opting in vs opting out of influenza vaccination. (Research letter) JAMA 2010 Jul 7;304(1):43-4 [Extract]
Charland KM, Brownstein JS, Verma A, et al. Increased influenza-related healthcare utilization by residents of an urban aboriginal community. Epidemiol Infect 2011 Dec;139(12):1902-8 [Abstract]
Charland KM, Brownstein JS, Verma A, et al. Socio-economic disparities in the burden of seasonal influenza: the effect of social and material deprivation on rates of influenza infection. PLoS ONE 2011 Feb 17;6(2):e17207 [Full text]
Charu V, Viboud C, Simonsen L, et al. Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren. PLoS ONE 2011 Nov 7;6(11):e26282 [Full text]
Chavarrias VL, Broberg E, Nicoll A. Preliminary implications for Europe of the 2011 influenza season in five temperate southern hemisphere countries. Euro Surveill 2011 Dec 15;16(50):pii=20044 [Full text]
Chen G-W, Yang C-C, Tsao K-C, et al. Influenza A virus PB1-F2 gene in recent Taiwanese isolates. Emerg Infect Dis 2004 Apr;10 (4):630-8 [Full text]
Chen GL, Lamirande EW, Yang CF, et al. Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets. J Virol 2010 Aug;84(15):7695-702 [Abstract]
Chen GL, Min JY, Lamirande EW, et al. Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets. J Infect Dis 2011 Apr 1;203(7):930-6 [Abstract]
Chen GW, Shih SR, Hsiao MR, et al. Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol 2007 May;45(5):1515-22 [Abstract]
Chen J, Deng YM. Influenza viral antigen variation, host antibody production, and new approach to control epidemics. Virol J 2009 Mar 13;6:30 [Abstract]
Chen J, Zhang F, Fang F, et al. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody. BMC Infect Dis 2007 Oct 16;7:118 [Abstract]
Chen PS, Tsai FT, Lin CK, et al. Ambient influenza and avian influenza virus during dust storm days and background days. Environ Health Perspect 2010 Sep;118(9):1211-6 [Abstract]
Chen WH, Cross AS, Edelman R, et al. Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine 2011 Apr 5;29(16):2865-73 [Abstract]
Chen Z, Zhou H, Jin H. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response. Vaccine 2010 May 28;28(24):4079-85 [Full text]
Cheng PKC, To APC, Leung TWC, et al. Oseltamivir- and amantadine-resistant influenza virus A (H1N1). (Letter) Emerg Infect Dis 2010 Jan;16(1):155-6 [Full text]
Cheng X, Eisenbraun M, Xu Q, et al. H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines. PLoS ONE 2009 Feb 11;4(2):e4336 [Full text]
Chi RC, Neuzil KM, Lipsky BA, et al. Where high-risk adults receive influenza vaccine during a shortage. Arch Intern Med 2007 Nov 26;167(21):2366-8 [Extract]
Chi RC, Rock MT, Neuzil KM. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010 May 15;50(10):1331-8 [Abstract]
Chittaro M, Turello D, Calligaris L, et al. Impact of vaccinating HCWs on the ward and possible influence of avian flu threat. Infection 2009 Feb;37(1):29-33 [Abstract]
Chiu SS, Chan KH, Wong WHS, et al. Age-matched comparison of children hospitalized for 2009 pandemic H1N1 influenza with those hospitalized for seasonal H1N1 and H3N2. PLoS ONE 2011 Jul 20;6(7):e21837 [Full text]
Chiu SS, Peiris JSM, Chan KH, et al. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007 Jun;119(6):1076-82 [Abstract]
Cho BH, Kolasa MS, Messonnier ML. Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season. Am J Infect Control 2008 Oct;36(8):582-7 [Abstract]
Choe YJ, Cho H, Kim SN, et al. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010. Vaccine 2011 Oct 13;29(44):7727-32 [Abstract]
Chou CH, Liou WP, Hu KI, et al. Bell's palsy associated with influenza vaccination: two case reports. Vaccine 2007 Apr 12;25(15):2839-41 [Abstract]
Chow A, Ma S, Ling AE, et al. Influenza-associated deaths in tropical Singapore. Emerg Infect Dis 2006 Jan;12(1):114-21 [Full text]
Christakis NA, Fowler JH. Social network sensors for early detection of contagious outbreaks. PLoS ONE 2010 Sep 15;5(9):e12948 [Full text]
Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virology J 2008 Apr 28;5:52 [Abstract]
Christian LM, Iams JD, Porter K, et al. Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine 2011 Nov 8;29(48):8982-7 [Abstract]
Christini AB, Shutt KA, Byers KE. Influenza vaccination rates and motivators among healthcare worker groups. Infect Control Hosp Epidemiol 2007 Feb;28(2):171-7 [Abstract]
Chuaychoo B, Wongsurakiat P, Nana A, et al. The immunogenicity of intradermal influenza vaccination in COPD patients. Vaccine 2010 May 28;28(24):4045-51 [Full text]
Chui KKH, Cohen SA, Naumova EN. Snowbirds and infections--new phenomena in pneumonia and influenza hospitalizations from winter migration of older adults: a spatiotemporal analysis. BMC Public Health 2011 Jun 7;11:444 [Abstract]
Chun S, Li C, Domselaar GV, et al. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 2008 Nov 11;26(48):6068-76 [Abstract]
Chung EY, Huang L, Schneider L. Safety of influenza vaccine administration in egg-allergic patients. Pediatrics 2010 May;125(5):e1024-30 [Abstract]
Ciancio BC, Meerhoff TJ, Kramarz P, et al. Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveill 2009 Nov 19;14(46):pii:19412 [Full text]
Cioppa GD, Vesikari T, Sokal E, et al. Trivalent and quadrivalent MF59-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. Vaccine 2011 Nov 3;29(47):8696-704 [Abstract]
Clark SJ, Cowan AE, Wortley PM. Influenza vaccination attitudes and practices among US registered nurses. Am J Infect Control 2009 Sep;37(7):551-6 [Abstract]
Coady MH, Galea S, Blaney S, et al. Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. Am J Public Health 2008 Jul;98(7):1314-21 [Abstract]
Cobey S, Pascual M, Dieckmann U. Ecological factors driving the long-term evolution of influenza's host range. Proc Biol Sci 2010 Sep 22;227(1695):2803-10 [Abstract]
Coffin SE, Zaoutis TE, Wheeler Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007 Apr(4);119:740-8 [Abstract]
Cohen C, Simonsen L, Kang JW, et al. Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis 2010 Dec 15;51(12):1362-9 [Full text]
Cohen NJ, Morita JY, Plate DK, et al. Control of an outbreak due to an adamantane-resistant strain of influenza A (H3N2) in a chronic care facility. Infection 2008 Oct;36(5):458-62 [Abstract]
Cohen S, Alper CM, Doyle WJ, et al. Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza A virus. Psychosom Med 2006 Nov-Dec;68(6):809-15 [Abstract]
Cohen SA, Ahmed S, Klassen AC, et al. Childhood hib vaccination and pneumonia and influenza burden in US seniors. Vaccine 2010 Jun 17;28(28):4462-69 [Full text]
Cohen SA, Klassen AC, Ahmed S, et al. Trends for influenza and pneumonia hospitalization in the older population: age, period, and cohort effects. Epidemiol Infect 2010 Aug;138(8):1135-45 [Abstract]
Coleman LA, Kieke B, Irving S, et al. Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). Vaccine 2011 Jan 10;29(3):387-90 [Abstract]
Coleman MS, Fontanesi J, Meltzer MK, et al. Estimating medical practice expenses from administering adult influenza vaccinations. Vaccine 2005 Jan 4;23(7):915-23 [Abstract]
Coler RN, Baldwin SL, Shaverdian N, et al. A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS ONE 2010 Oct 27;5(10):e13677 [Full text]
Colina R, Costa-Mattioli M, Dowling RJO, et al. Translational control of the innate immune response through IRF-7. Nature 2008 Mar 20;452(7185):323-8 [Abstract]
Collin N, de Radigues X, WHO H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009 Aug 20;27(38):5184-6 [Abstract]
Combadiere B, Vogt A, Mahe B, et al. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One 2010 May 26;5(5):e10818 [Full text]
Cong Y, Wang G, Guan Z, et al. Reassortant between human-like H3N2 and avian H5 subtype influenza A viruses in pigs: a potential public health risk. PLoS ONE 2010 Sep 7;5(9):e12591 [Full text]
Conti G, Magliani W, Conti S, et al. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection. Antimicrob Agents Chemother 2008 Dec;52(12):4331-7 [Abstract]
Cooper DL, Smith GE, Regan M, et al. Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatio-temporal analysis of syndromic data. BMC Med 2008 Jun 26;6:16 [Abstract]
Coory M, Grant K, Kelly H. Influenza-like illness surveillance using a deputizing medical service corresponds to surveillance from sentinel general practices. Euro Surveill 2009 Nov 5;14(44):pii:19387 [Full text]
Corti D, Suguitan AL Jr, Pinna D, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 2010 May 3;120(5):1663-73 [Full text]
Corti D, Voss J, Gamblin SJ, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011 Aug 12;333(6044):850-6 [Abstract]
Couch RB, Winokur P, Brady R, et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 2007 Nov 1;25(44):7656-63 [Abstract]
Couto CR, Pannuti CS, Paz JP, et al. Fighting misconceptions to improve compliance with influenza vaccination among health care workers: an educational project. PLoS ONE 2012 Feb 6;7(2):e30670 [Full text]
Cowling BJ, Chan KH, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households. Ann Intern Med 2009 Oct 6;151(7):437-46 [Full text]
Cowling BJ, Lau EHY, Lam CLH, et al. Effects of school closures, 2008 winter influenza season, Hong Kong. Emerg Infect Dis 2008 Oct;14(10):1660-2 [Full text]
Cowling BJ, Ng S, Ma ESK, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010 Dec 15;51(12):1370-9 [Abstract]
Cowling BJ, Zhou Y, Ip DKM, et al. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect 2010 Apr;138(4):449-56 [Abstract]
Cox CM, Neises D, Garten RJ, et al. Swine influenza virus A (H3N2) infection in human, Kansas, USA, 2009. (Letter) Emerg Infect Dis 2011 Jun;17(6):1143-4 [Full text]
Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children--how do they compare? (Editorial) N Engl J Med 2007 Feb 15;256(7):729-31 [Abstract]
Crawford LM. FDA's ongoing efforts to ensure the safety, effectiveness, and availability of influenza and other vaccines. Testimony before Senate Special Committee on Aging. Nov 16, 2004 [Full text]
Creanga AA, Kamimoto L, Newsome K, et al. Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. Am J Obstet Gynecol 2011 Jun;204(6):S38-45 [Abstract]
Crepey P, Barthelemy M. Detecting robust patterns in the spread of epidemics: a case study of influenza in the United States and France. Am J Epidemiol 2007 Dec 1;166(11):1244-51 [Abstract]
Crowe SR, Merrill JT, Vista ES, et al. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum 2011 Aug;63(8):2396-406 [Abstract]
Cruz-Aponte M, McKiernan EC, Herrera-Valdez MA. Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity. BMC Infect Dis 2011 Aug 1;11:207 [Abstract]
D'Angio CT, Heyne RJ, Duara S, et al. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants. Pediatr Infect Dis J 2011 Jul;30(7):570-4 [Abstract]
D'Heilly SJ, Nichol K. Work-site-based influenza vaccination in healthcare and non-healthcare settings. Infect Control Hosp Epidemiol 2004 Dec;25(11):941-5 [Abstract]
Damme PV, Arnou R, Kafeja F, et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. BMC Infect Dis 2010 May 26;10:134 [Abstract]
Daniels TL, Talbot TR. Unmasking the confusion of respiratory protection to prevent influenza-like illness in crowded community settings. (Editorial) J Infect Dis 2010 Feb 15;201(4):483-5 [Full text]
Dao CN, Kamimoto L, Nowell M, et al. Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States. J Infect Dis 2010 Sep 15;202(6):881-8 [Abstract]
Dapat C, Suzuki Y, Saito R, et al. Rare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs. Emerg Infect Dis 2010 Mar;16(3):493-6 [Full text]
Das K, Ma LC, Xiao R, et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci 2008 Sep 2;105(35):13093-8 [Abstract, with link to free full text]
Daugherty EL, Speck KA, Rand CS, et al. Perceptions and influence of hospital influenza vaccination policy. Infect Control Hosp Epidemiol 2011 May;32(5):449-55 [Abstract]
Daum LT, Shaw M, Klimov AI, et al. Influenza A (H3N2) outbreak, Nepal. Emerg Infect Dis 2005 Aug;11(8):1186-91 [Full text]
Davila JC, Payne DC, Zhang Y, et al. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Vaccine 2008 Mar 17;26(12):1577-84 [Abstract]
Dawood F, Fiore A, Kamimoto L, et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008. Ped Infect Dis J 2010 Jul;29(7):585-90 [Abstract]
Dawood FS, Fry AM, Muangchana C, et al. A method for estimating vaccine preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study. Vaccine 2011 Jun 10;29(26):4416-21 [Abstract]
Dawood FS, Kamimoto L, D'Mello TA, et al. Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009. Pediatrics 2011 (published online Jun 6) [Abstract]
Dawson ED, Moore CL, Smagala JA, et al. MChip: a tool for influenza surveillance. Anal Chem 2006 Nov 15;78(22):7610-5 [Abstract]
de Bruijn I, Meyer I, Gerez L, et al. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. Vaccine 2007 Dec 21;26(21):119-27 [Abstract]
de Mello WA, de Paiva TM, Ishida MA, et al. The dilemma of influenza vaccine recommendations when applied to the tropics: the Brazilian case examined under alternative scenarios. PLoS ONE 2009 Apr 8;4(4):e5095 [Full text]
del Campo MT, Villamor JM, Caceres S, et al. 2009-2010 seasonal and pandemic A (H1N1) influenza vaccination among healthcare workers. Vaccine 2011 May 9;29(20):3703-7 [Full text]
Deng YM, Caldwell N, Barr IG. Rapid detection and subtyping of human influenza A viruses and reassortants by pyrosequencing. PLoS ONE 2011 Aug 19;6(8):e23400 [Full text]
Denis J, Acosta-Ramirez E, Zhao Y, et al. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV). Vaccine 2008 Jun 25;26(27-28):3395-403 [Abstract]
Desbiens NA. A 5-year experience with influenza prevention and containment in a program of all-inclusive care for elderly adults. Am J Infect Control 2005 May;33(4):238-42 [Abstract]
DesRoches CM, Blendon RJ, Benson JM. Americans' responses to the 2004 influenza vaccine shortage. Health Affairs 2005 May 24(3):822-31 [Abstract]
DeStefano F, Haber M, Currivan D, et al. Factors associated with social contacts in four communities during the 2007-2008 influenza season. Epidemiol Infect 2011 Aug 1;139(8):1181-90 [Abstract]
Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007 Jul 15;196(2):249-57 [Full text]
Dharan NJ, Fry AM, Kieke BA, et al. Clinical and virologic outcomes in patients with oseltamivir-resistant seasonal influenza A (H1N1) infections: results from a clinical trial. Influenza Other Respi Viruses 2011 (published online Nov 26) [Abstract]
Dharan NJ, Gubareva LV, Meyer JJ, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009 Mar 11;301(10):1034-41 [Full text]
Dharan NJ, Patton M, Siston AM, et al. Outbreak of antiviral drug-resistant influenza A in long-term care facility, Illinois, USA, 2008. Emerg Infect Dis 2009 Dec;15(12):1973-6 [Full text]
Dias A, Bouvier D, Crepin T, et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009 Apr 16;458:914-8 [Abstract]
Diaz KT, Smaldone GC. Quantifying exposure risk: surgical masks and respirators. Am J Infect Control 2010 Sep;38(7):501-8 [Abstract]
Dilantika C, Sedyaningsih ER, Kasper MR, et al. Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness. BMC Infect Dis 2010 Jan 7;10:3 [Abstract]
Dimmock NJ, Rainsford EW, Scott PD, et al. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 2008 Sep;82(17):8570-78 [Abstract]
Ding Y, Zangwill KM, Hay JW, et al. Cost-benefit analysis of in-hospital influenza vaccination of postpartum women. Obstet Gynecol 2012 Feb;119(2 pt 1):306-14 [Abstract]
Dodds L, McNeill SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007 Feb 13;176(4):463-8 [Abstract]
Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. (Commentary) J Clin Invest 2008 Oct 1;118(10):3273-5 [Full text]
Dolin R. Influenza: interpandemic as well as pandemic disease. (Perspective) N Engl J Med 2005 Dec 15;353(24):2535-7 [Extract]
Donato AA, Motz LM, Wilson G, et al. Efficacy of multiple influenza vaccine delivery systems in a single facility. Infect Control Hosp Epidemiol 2007 Feb;28(2):219-21 [Abstract]
Dong C, Ying L, Yuan D. Detecting transmission and reassortment events for influenza A viruses with genotype profile method. Virol J 2011 Aug 9;8:395 [Abstract]
Donis RO, Cox NJ. Prospecting the influenza hemagglutinin to develop universal vaccines. (Editorial) Clin Infect Dis 2011 Apr 15;52(8):1010-2 [Abstract]
Doratotaj S, Macknin ML, Worley S. A novel approach to improve influenza vaccination rates among health care professionals: a prospective randomized controlled trial. Am J Infect Control 2008 May;36(4):301-303 [Abstract]
Doshi P. Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health 2008 May;98(5):939-45 [Abstract]
Douce RW, Aleman W, Chicaiza-Ayala W, et al. Sentinal surveillance of influenza-like-illness in two cities of the tropical country of Ecuador: 2006-2010. PLoS ONE 2011 Aug 24;6(8):e22206 [Full text]
Dower J, Donald M, Begum N, et al. Patterns and determinants of influenza and pneumococcal immunization among adults with chronic disease living in Queensland, Australia. Vaccine 2011 Apr 5;29(16):3031-7 [Abstract]
Driskell JD, Jones CA, Tompkins SM, et al. One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles. Analyst 2011 Aug 1;136(15):3083-90 [Abstract]
Du L, Zhou Y, Jiang S. Research and development of universal influenza vaccines. Microbes Infect 2010 Apr;12(4):280-6 [Full text]
Dugas AF, Hsieh YH, Levin SR, et al. Google Flu Trends: correlation with emergency department influenza rates and crowding metrics. Clin Infect Dis 2012 (published online Jan 8) [Abstract]
Durando P, Fenoglio D, Boschini A, et al. Safety and immunogenicity of two influenza subunit vaccines, with or without MF59 adjuvant, administered to HIV-1 seropositive and seronegative adults. Clin Vaccine Immunol 2008 Feb;15(2):253-9 [Abstract]
Dushoff J, Plotkin JB, Viboud C, et al. Vaccinating to protect a vulnerable subpopulation. PLoS Med 2007 May;4(5):e174 [Full text]
Duval X, van der Wef S, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS MED 2010 Nov 2;7(11):e1000362 [Full text]
Duwe S, Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Method 2008 Nov;153(2):134-41 [Abstract]
Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006 Nov 20;185(10 suppl):S48-53 [Full text]
Eames KTD, Brooks-Pollock E, Paolotti D, et al. Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort. Epidemiol Infect 2011 (published online Sep 12) [Abstract]
Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005 Nov;5(11):718-25 [Abstract]
ECDC (European Centre for Disease Prevention and Control). Likely scenarios for influenza in 2010 and the 2010/2011 influenza season in Europe and the consequent work priorities. Mar 8, 2010 [Full text]
ECDC Influenza Project Team. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update. Eurosurveill 2008 Feb 7;13(6):pii=8032 [Full text]
EDCD Influenza Team. Start of the influenza season 2010-11 in Europe dominated by 2009 pandemic influenza A(H1N1) virus. Euro Surveill 2010 Dec 16;15(50):pii=19753 [Full text]
Effler PV, Chu C, He H, et al. Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA. Emerg Infect Dis 2010 Feb;16(2):304-7 [Full text]
Ehrenstein BP, Hanses F, Blaas S, et al. Perceived risks of adverse effects and influenza vaccination: a survey of hospital employees. Eur J Public Health 2010 Oct;20(5):495-9 [Abstract]
Ehrlich HJ, Berezuk G, Fritsch S, et al. Clinical development of a vero cell culture-derived seasonal influenza vaccine. Vaccine 2011 (published online Dec 13) [Abstract]
Ehrlich HJ, Singer J, Berezuk G, et al. A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals. Clin Infect Dis 2012 (published online Jan 19) [Abstract]
Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303 [Abstract]
Eick AA, Uyeki TM, Klimov A, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011 Feb;165(2):104-11 [Abstract]
Eick AA, Wang Z, Hughes H, et al. Comparison of the trivalent live attenuated vs inactivated influenza vaccines among US military service members. Vaccine 2009 Jun 2;27(27):3568-75 [Abstract]
Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008 Nov;122(5):911-9 [Abstract]
Ekiert DC, Friesen RH, Bhabha G, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011 (published online Jul 7) [Abstract]
El Sahly HM, Keitel WA. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine. Expert Rev Vaccines 2008 Aug;7(6):713-9 [Abstract]
ElHefnawi M, Alaidi O, Mohamed N, et al. Identification of novel conserved functional motifs across most influenza viral A strains. Virol J 2011 Jan 27;8:44 [Abstract]
Eliasson DG, Bakkouri KE, Schon K, et al. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. Vaccine 2008 Feb 26;26(9);1243-52 [Abstract]
Ellis J, Galiano M, Pebody R, et al. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 2011 Jan 6;16(1):pii=19760 [Full text]
Engler RJM, Nelson MR, Klote MM, et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008 Dec 8/22;168(22):2405-14 [Abstract]
Esolen LM, Kilheeney KL, Merkle RE, et al. An alternate approach to improving healthcare worker influenza vaccination rates. Infect Control Hosp Epidemiol 2011 Jul;32(7):703-5 [Full text]
Esposito S, Bosis S, Pelucchi C, et al. Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy. BMC Public Health 2008 Dec 23;8:22 [Abstract]
Esposito S, Cantarutti L, Molteni CG, et al. Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect 2011 May;62(5):379-87 [Abstract]
Esposito S, Daleno C, Picciolli I, et al. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine 2011 Oct 13;29(44):7606-10 [Abstract]
Esposito S, Gasparini C, Martelli A, et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 2008 Aug 26;26(36):4664-8 [Abstract]
Esposito S, Molteni CG, Daleno C, et al. Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. BMC Infect Dis 2011 Oct 12;11:271 [Abstract]
Esposito S, Molteni CG, Daleno C, et al. Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy. Virol J 2010 Aug 26;7:202 [Abstract]
Esposito S, Molteni CG, Daleno C, et al. Impact of pandemic A/H1N1/2009 influenza on children and their families: comparison with seasonal A/H1N1 and A/H3N2 influenza viruses. J Infect 2011 Oct;63(4):300-7 [Abstract]
Esposito S, Principi N. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination. Vaccine 2011 Oct 6;29(43):7535-41 [Abstract]
Esposito S, Tremolati E, Bellasio M, et al. Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children. Vaccine 2007 Jul 20;25(29):5283-9 [Abstract]
Eurosurveillance Editorial team. New WHO influenza vaccine recommendations for 2007-2008 season, northern hemisphere. Eurosurveillance Weekly 2007 Apr 5;12(4):pii=3171 [Full text]
Even-Or O, Joseph A, Itskovitz-Cooper N, et al. A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity. Vaccine 2011 Mar 16;29(13):2474-86 [Abstract]
Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza virus in human exhaled breath: an observational study. PLoS ONE 2008 Jul 16;3(7):e2691 [Full text]
Fairbrother G, Cassedy A, Ortega-Sanchez IR, et al. High Costs of influenza: direct medical costs of influenza disease in young children. Vaccine 2010 Jul 12;28(31):4913-9 [Abstract]
Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 2007 Feb 26;167(4):354-60 [Abstract]
Falsey AR, Treanor JJ, Tornieporth N, et al. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009 Jul 15;200(2):172-80 [Abstract]
Falsey AR. Half-dose influenza vaccine: stretching the supply or wasting it? (Editorial) Arch Intern Med 2008 Dec 8/22;168(22):2402-3 [Extract]
Falsey AR. New emerging technologies and the intradermal route: the novel way to immunize against influenza. Vaccine 2010 Aug 14;28(suppl 4):D24-32 [Abstract]
Fan X, Zhu H, Zhou B, et al. Emergence and dissemination of a swine H3N2 reassortant with 2009 pandemic H1N1 genes in pigs in China. J Virol 2011 (published online Dec 14) [Abstract]
FAO. FAO guidelines for surveillance of pandemic H1N1/2009 and other influenza viruses in swine populations. Aug 11, 2009 [Full text]
Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006 Nov 1;194(suppl 2):S73-6 [Abstract]
FDA. FDA approves vaccines for the 2010-2011 influenza season. Released Jul 30, 2010 [Full text]
FDA. FDA clears first single use face mask for children. Sep 28, 2011, news release [Full text]
FDA. FDA clears first test designed to detect and identify 12 respiratory viruses from single sample. Jan 3, 2008, news release [Full text]
FDA. FDA communication on use of jet injectors with influenza vaccines. Oct 21, 2011 [Full text]
FDA. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. Released Mar 2, 2010 [Full text]
FDA. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. May 31, 2007 [Full text]
Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3 [Full text]
Feng L, Mounts AW, Feng Y, et al. Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine 2010 Sep 24;28(41):6778-82 [Abstract]
Ferdinands JM, Belongia EA, Nwasike C, et al. Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness. Vaccine 2011 Feb 24;29(10):1935-40 [Abstract]
Ferdinands JM, Denison AM, Dowling NF, et al. A pilot study of host genetic variants associated with influenza-associated deaths among children and young adults. Emerg Infect Dis 2011 Dec;17(12):2294-302 [Full text]
Ferdinands JM, Shay DK. Magnitude of potential biases in a simulated case-control study of the effectiveness influenza vaccination. Clin Infect Dis 2011 (published online Nov 17) [Abstract]
Ferko B, Kittel C, Romanova J, et al. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol 2006 Dec;80(23):11621-7 [Abstract]
Ferng YH, Wong-McLoughlin J, Barrett A, et al. Barriers to mask wearing for influenza-like illnesses among urban Hispanic households. Public Health Nurs 2011 Jan-Feb;28(1):13-23 [Abstract]
Field RI, Caplan AL. Evidence-based decision making for vaccines: the need for an ethical foundation. Vaccine 2011 (published online Dec 21) [Abstract]
Fielding JE, Grant KA, Papadakis G, et al. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008. BMC Infect Dis 2011 Jun 14;11:170 [Abstract]
Finelli L, Chaves SS. Influenza and acute myocardial infarction. (Commentary) J Infect Dis 2011 Jun 15;203(12):1701-4 [Abstract]
Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008 Oct;122(4):805-11 [Abstract]
Finkelman BS, Viboud C, Koelle K, et al. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS ONE 2007 Dec 12;2(12):e1296 [Full text]
Finkelstein S, Prakash S, Nigmatulina K, et al. A home toolkit for primary prevention of influenza by individuals and families. Disaster Med Public Health Prep 2011 Dec;5(4):266-71 [Abstract]
Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011 Jan 21;60(RR1):1-24 [Full text]
Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 2010 Jul 29;59(Early release):1-62 [Full text]
Fisher BM, Scott J, Hart J, et al. Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S107-11 [Abstract]
Fisman DN, Tuite AR. Estimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in Canada. PLoS ONE 2011 Nov 14;6(11):e27420 [Full text]
Fleishman SJ, Whitehead TA, Ekiert DC, et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 2011 May 13;332(6031):816-21 [Full text]
Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Ped Infect Dis J 2006 Oct;15(10):860-9 [Abstract]
Fleming DM, Verlander NQ, Elliot AJ, et al. An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006. Epidemiol Infect 2010 Sep;138(9):1281-8 [Abstract]
Flood EM, Ryan KJ, Rousculp MD, et al. A survey of children's preferences for influenza vaccine attributes. Vaccine 2011 Jun 10;29(26):4334-40 [Abstract]
Foppa IM, Hossain MM. Revised estimates of influenza-associated excess mortality, United States, 1995 through 2005. Emerg Themes Epidemiol 2008;5(1):26 (published online Dec 30) [Abstract]
Forrest BD, Steele AD, Hiemstra L, et al. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Vaccine 2011 May 9;29(20):3633-9 [Abstract]
Foxwell AR, Roberts L, Lokuge K, et al. Transmission of influenza on international flights, May 2009. Emerg Infect Dis 2011 Jul;17(7):1188-94 [Full text]
Fraaij PLA, Heikkinen T. Seasonal influenza: the burden of disease in children. Vaccine 2011 Oct 6;29(43):7524-8 [Abstract]
France EK, Smith-Ray R, McClure D, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits. Arch Pediatr Adolesc Med 2006 Dec 160(12):1277-83 [Abstract]
Francis DP, Grohmann G. WHO influenza vaccine technology transfer initiative: role and activities of the Technical Advisory Group. Vaccine 2011 Jul 1;29(suppl 1):A45-7 [Abstract]
Frasca D, Diaz A, Romero M, et al. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010 Nov 29;28(51):8077-84 [Abstract]
Fraser C, Riley S, Anderson RM, et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 2004 Apr 20;101(16):6146-51 [Abstract]
Frech SA, Kenney RT, Spyr CA, et al. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 2005 Jan 4;23(7):946-50 [Abstract]
Frenck RW Jr, Belshe R, Brady RC, et al. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone) administered by intradermal and intramuscular route in healthy adults. Vaccine 2011 Aug 5;29(34):5666-74 [Abstract]
Frey S, Vesikari T, Szymczakiewicz-Multanowska A, et al. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010 Nov 1;51(9):997-1004 [Full text]
Friede M, Palkonyay L, Alfonso C, et al. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Vaccine 2011 Jul 1;29(suppl 1):A2-7 [Abstract]
Friedl A, Aegerter C, Saner E, et al. An intensive 5-year-long influenza vaccination campaign is effective among doctors but not nurses. Infection 2011 (published online Sep 29) [Abstract]
Friesen RH, Koudstaal W, Koldijk MH, et al. New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLoS One 2010 Feb 8;5(2):e9106 [Full text]
Frisbie B, Tang YW, Griffin M, et al. Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples? J Clin Microbiol 2004 Mar;42(3):1181-4 [Abstract]
Fu TM, Freed DC, Horton MS, et al. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus. Virology 2009 Mar 1;385(1):218-26 [Abstract]
Fujimoto C, Takeda N, Matsunaga A, et al. Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults. Influenza Other Respi Viruses 2012 (published online Jan 6) [Abstract]
Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 2008 Mar;82(6):2772-83 [Abstract]
Fukuda K, Kieny MP. Different approaches to influenza vaccination. N Engl J Med 2006 Dec 14;355(24):2586-7 [Full text]
Furuse Y, Suzuki A, Kamigaki T, et al. Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol 2009 Mar 1;47(3):841-4 [Abstract]
Gaglia MA Jr, Cook RL, Kraemer KL, et al. Patient knowledge and attitudes about antiviral medication and vaccination for influenza in an internal medicine clinic. Clin Infect Dis 2007 Nov 1;45(9):1182-8 [Abstract]
Gallagher KM, Juhasz M, Harris NS, et al. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis 2007 Aug 1;196(3):339-46 [Abstract]
Galvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci 2007 Mar 27;104(13):5692-7 [Abstract]
GAO (Government Accountability Office) Influenza vaccine: federal investments in alternative technologies and challenges to development and licensure. GAO-11-435. Jun 27, 2011 [Summary with link to full text]
GAO (Government Accountability Office). Federal challenges in responding to influenza outbreaks. Testimony of Janet Heinrich before Special Committee on Aging, US Senate. GAO-04-1100T. Sep 28, 2004 [Full text]
GAO (Government Accountability Office). Flu vaccine: recent supply shortages underscore ongoing challenges. Congressional testimony by Janet Heinrich. GAO-05-177T. Nov 18, 2004 [Full text]
GAO (US Government Accountability Office). Influenza vaccine: issues related to production, distribution, and public health messages. GAO-08-27. Released Nov 16, 2007 (but dated Oct 31) [Full text]
Gao Q, Palese P. Rewiring the RNAs of influenza virus to prevent reassortment. Proc Natl Acad Sci 2009 Sep 15;106(37):15891-6 [Abstract]
Garcia J, Sovero M, Torres AL, et al. Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza Other Resp Viruses 2009 Mar;3(2):69-74 [Abstract]
Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E, et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009 Oct 6;339:b3928 [Full text]
Gargano LM, Pazol K, Sales JM, et al. Multicomponent interventions to enhance influenza vaccine delivery to adolescents. Pediatrics 2011 (published online Oct 10) [Abstract]
Garigliany MM, Habyarimana A, Lambrecht B, et al. Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice. Emerg Infect Dis 2010 Apr;16(4):595-603 [Full text]
Gatrad AR, Shafi S, Memish ZA, et al. Hajj and the risk of influenza (Editorial). BMJ 2006 Dec 9;333(7580):1182-3 [Extract]
Gavazzi G, Filali-Zegzouti Y, Guyon AC, et al. French healthcare workers in geriatric healthcare settings staunchly opposed to influenza vaccination: the VESTA study. Vaccine 2011 Feb 11;29(8):1611-6 [Abstract]
Gaydos JC, Top FH Jr, Hodder RA, et al. Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 2006 Jan;12(1):23-8 [Full text]
Gazmararian JA, Coleman M, Prill M, et al. Influenza vaccination of health care workers: policies and practices of hospitals in a community setting. Am J Infect Control 2007 Sep;25(7):441-7 [Abstract]
Ge Q, Filip L, Bai A, et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci 2004 Jun 8;101(23):8676-81 [Abstract]
Georgantopoulos P, Bergquist EP, Knaup RC, et al. Importance of routine public health influenza surveillance: detection of an unusual w-shaped influenza morbidity curve. Am J Epidemiol 2009 Dec 15;170(12):1533-40 [Abstract]
Gerberding JL. Influenza and influenza vaccine safety and supply. Statement before House Committee on Appropriations Subcommittee on Labor, Health and Human Services & Education. Oct 5, 2004 [Full text]
Gerhard W, Mozdzanowska K, Zharikova D. Prospects for universal influenza virus vaccine. Emerg Infect Dis 2006 Apr; 12(4):569-74 [Full text]
Gerloff NA, Kremer JR, Mossong J, et al. Genomic diversity of oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08. (Letter) Emerg Infect Dis 2009 Sep;15(9):1523-4 [Full text]
Gessner BD, Shindo N, Briand S. Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review. Lancet Infect Dis 2011 Mar;11(3):223-35 [Abstract]
Ghedin E, Fitch A, Boyne A, et al. Mixed infection and the genesis of influenza diversity. J Virol 2009 Sep;83(17):8832-41 [Abstract]
Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005 Oct 20;437(7062):1162-6 [Abstract]
Ghendon YZ, Markuskin SG, Akopova II, et al. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine. Vaccine 2005 Sep 7;23(38):4678-84 [Abstract]
Ghosh TS, Vogt RL. Active influenza surveillance at the local level: a model for local health agencies. Am J Public Health 2008 Feb;98(2):213-5 [Abstract]
Giezeman KM, Nauta J, de Bruijn IA, et al. Trivalent inactivated subunit influenza vaccine Influvac: 25-year experience of safety and immunogenicity. Vaccine 2009 Apr 21;27(18):2414-7 [Abstract]
Gill TK, Taylor AW, Watson M. Trends in influenza immunisation amongst an elderly Australian community. Vaccine 2007 Jul 20;25(29):5428-32 [Abstract]
Ginsberg J, Mohebbi MH, Patel RS, et al. Detecting influenza epidemics using search engine query data. Nature 2009 Feb 19;457:1012-4 [Abstract]
Glasser J, Taneri D, Feng Z, et al. Evaluation of targeted influenza vaccination strategies via population modeling. PLoS ONE 2010 Sep 17;5(9):e12777 [Full text]
Glezen WP, Gaglani MJ, Kozinetz CA, et al. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis 2010 Dec 1;202(11):1626-33 [Abstract]
Glezen WP. Broadening indications for maternal influenza vaccination. (Editorial) J Infect Dis 2011 Oct 15;204(8):1151-3 [Extract]
Glezen WP. Cell-culture-derived influenza vaccine production. (Commentary) Lancet 2011 Feb 26;377(9767):698-700 [Extract]
Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76 [Full text]
Glezen WP. Modifying clinical practices to manage influenza in children effectively. Pediatr Infect Dis J 2008 Aug;27(8):738-43 [Abstract]
Glezen WP. Prevention and treatment of seasonal influenza. N Engl J Med 2008 Dec 11;359(24):2579-85 [Full text]
Gocnik M, Fislova F, Mucha V, et al. Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J Gen Virol 2008 Apr;89(4):958-67 [Abstract]
Goddard N, Zucs P, Ciancio B, et al. Start of the influenza season 2008-2009 in Europe - increasing influenza activity moving from west to east dominated by A(H3N2). (Rapid communications) Eurosurveill 2009 Jan 22;14(3):pii=19097 [Full text]
Godin G, Vezina-Im LA, Naccache H. Determinants of influenza vaccination among healthcare workers. Infect Control Hosp Epidemiol 2010 Jul;31(7):689-93 [Abstract]
Godlee F, Clarke M. Why don't we have all the evidence on oseltamivir? (Editorial) BMJ 2009 Dec 8;339:b5351 [Full text]
Goldstein AO, Kincade JE, Gamble G, et al. Policies and practices for improving influenza immunization rates among healthcare workers. Infect Control Hosp Epidemiol 2004 Dec;25(11):908-11 [Abstract]
Goldstein AO, Kincade JE, Resnick JE, et al. Policies to increase influenza and pneumococcal immunizations in chronically ill and institutionalized settings. Am J Infect Control 2005 Oct;33(8):463-8 [Abstract]
Goldstein E, Cobey S, Takahashi S, et al. Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS Med 2011 Jul 5;8(7):e1001051 [Full text]
Goldstein E, Dushoff J, Ma J, et al. Reconstructing influenza incidence by deconvolution of daily mortality time series. Proc Natl Acad Sci 2009 Dec 22;106(51):21825-9 [Abstract]
Goodman MJ, Nordin JD, Harper P, et al. The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age. Pediatrics 2006 May;117(5):e821-6 [Abstract]
Gooskens J, Jonges M, Claas ECJ, et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA 2009;301(10):1042-6 [Full text]
Gooskens J, Jonges M, Claas ECJ, et al. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009 May 15;199(10):1435-41 [Abstract]
Gordon A, Ortega O, Kuan G, et al. Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis 2009 Mar;15(3):408-14 [Full text]
Gordon A, Saborio S, Videa E, et al. Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin Infect Dis 2010 Jun 1;50(11):1462-7 [Abstract]
Gordy JT, Jones CA, Rue J, et al. Surveillance of feral cats for influenza A virus in North Central Florida. Influenza Other Respi Viruses 2011 (published online Dec 30) [Abstract]
Goyal SM, Anantharaman S, Ramakrishnan MA, et al. Detection of viruses in used ventilation filters from two large public buildings. Am J Infect Control 2011 Sep;39(7):e30-8 [Abstract]
Gralton J, Tovey E, McLaws MY, et al. The role of particle size in aerosolized pathogen transmission: a review. J Infect 2011 Jan;62(1):1-13 [Abstract]
Gran JM, Iversen B, Hungnes O, et al. Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004. Epidemiol Infect 2010 Nov;138(11):1559-68 [Abstract]
Grandea III AG, Olsen OA, Cox TC, et al. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci 2010 Jul 13;107(28):12658-63 [Abstract]
Gravel C, Li C, Wang J, et al. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences. Vaccine 2010 Aug 16;28(36):5774-84 [Full text]
Grayson ML, Melvani S, Druce J, et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis 2009 Feb 1;48(3):285-91 [Abstract]
Greatorex JS, Page RF, Curran MD, et al. Effectiveness of common household cleaning agents in reducing the viability of human influenza A/H1N1. PLoS One 2010 Feb 1;5(2):e8987 [Full text]
Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis 2008 Apr;14(4):552-6 [Full text]
Gregersen JP. A quantitative risk assessment model of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine. Vaccine 2008 Jun 19;26(26):3332-40 [Abstract]
Gregersen JP. A risk-assessment model to rate the occurence and relevance of adventitious agents in the production of influenza vaccines. Vaccine 2008 Jun 19;26(26):3297-304 [Abstract]
Griffin BA, Jain AK, Davies-Cole J, et al. Early detection of influenza outbreaks using the DC Department of Health's syndromic surveillance system. BMC Public Health 2009 Dec 22;9:483 [Abstract]
Grijalva CG, Craig AS, Dupont WD, et al. Estimating influenza hospitalizations among children. Emerg Infect Dis 2006 Jan;12(1):103-9 [Full text]
Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics 2007 Jan;119(1):e6-11 [Full text]
Grijalva CG, Zhu Y, Simonsen L, et al. Establishing the baseline burden of influenza in preparation for the evaluation of a countrywide school-based influenza vaccination campaign. Vaccine 2010 Dec 10;29(1):123-9 [Abstract]
Grimaldi-Bensouda L, Alperovitch A, Besson G, et al. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011 (published online Jun 7) [Abstract]
Grimm D, Staeheli P, Hufbauer M, et al. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci 2007 Apr 17;104(16):6806-11 [Abstract]
Groth N, Montomoli E, Gentile C, et al. Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential phase I and phase II clinical trial. Vaccine 2009 Jan 29;27(5):786-91 [Abstract]
Gu Q, Sood N. Do people taking flu vaccines need them the most? PLoS ONE 2011 Dec 2;6(12):e26347 [Full text]
Guarner J, Paddock CD, Shieh WJ, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis 2006 Jul 15;43(2):132-40 [Abstract]
Guebre-Xabier M, Hammond SA, Ellingsworth LR, et al. Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice. J Virol 2004 Jul 15;78(14):1610-8 [Abstract]
Gundlapalli AV, Rubin MA, Samore MH, et al. Influenza, winter Olympiad, 2002. Emerg Infect Dis 2005 Jan;12(1):144-6 [Full text]
Guo L, Garten RJ, Foust AS, et al. Rapid identification of osteltamivir-resistant influenza A (H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay. Antiviral Res 2009 Apr;82(1):29-33 [Abstract]
Guo RN, Zheng HZ, Li JS, et al. A population-based study on incidence and economic burden of influenza-like illness in south China, 2008. Public Health 2011 Jun;125(6):389-95 [Abstract]
Gustin KM, Belser JA, Wadford DA, et al. Influenza virus aerosol exposure and analytical system for ferrets. Proc Natl Acad Sci 2011 May 17;108(20):8432-7 [Abstract]
Guthmann JP, Fonteneau L, Bonmarin I, et al. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine 2011 (published online Dec 15) [Abstract]
Guthrie T, Hobbs CG, Davenport V, et al. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults. J Infect Dis 2004 Dec 1;190(11):1927-35 [Abstract]
Ha JW, Schwahn AB, Downard KM. Proteotyping to establish gene origin within reassortant influenza viruses. PLoS ONE 2011 Jan 31;6(1):e15771 [Full text]
Hai R, Garcia-Sastre A, Swayne DE, et al. A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains. J Virol 2011 Jul;85(14):6832-43 [Abstract]
Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005 Feb 14;165(3):274-80 [Abstract]
Hak E, Wei F, Nordin J, et al. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004 Feb 1;189(3):450-8 [Abstract]
Hak E. Collaborative efforts are needed to improve use of influenza immunisation in Europe. (Editorial) Eurosurveill 2008 Oct 23;13(43):1 [Full text]
Hakim H, Gaur AH, McCullers JA. Motivating factors for high rates of influenza vaccination among healthcare workers. Vaccine 2011 Aug 11;29(35):5963-9 [Abstract]
Halasa N, Englund JA, Nachman S, et al. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Vaccine 2011 May 31;29(24):4110-5 [Abstract]
Halasa NB, Gerber MA, Chen Q, et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 2008 May 15;197(10):1448-54 [Abstract]
Halasa NB. Make new friends, but keep the old: influenza vaccines in children with cancer. (Editorial) J Infect Dis 2011 (published online Sep 23) [Abstract]
Haldar J, An D, Alvarez de Cienfuegos L, et al. Polymeric coatings that inactivate both influenza virus and pathogenic bacteria. Proc Natl Acad Sci 2006 Nov 21;103(47):17667-71 [Abstract]
Hale BG, Randall RE, Ortin J, et al. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008 Oct;89(10):2359-76 [Abstract]
Hall JS, Bentler KT, Landolt G, et al. Influenza infection in wild raccoons. Emerg Infect Dis 2008 Dec;14(12):1842-8 [Full text]
Halloran ME, Hayden FG, Yang Y, et al. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol 2007 Jan 15;165(2):212-21 [Abstract]
Halloran ME, Longini IM. Community studies for vaccinating schoolchildren against influenza. Science 2006 Feb 3;311(5761):615-6 [Full text]
Halloran ME, Piedra PA, Longini IM Jr, et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine 2007 May 16;25(20):4038-45 [Abstract]
Hambidge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA 2006 Oct 25;296(10):1990-7 [Abstract]
Hambidge SJ, Ross C, Glanz J, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics 2011 (published online Dec 12) [Abstract]
Hambridge SJ, Ross C, McClure D, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort. Vaccine 2011 Oct 26;29(46):8179-81 [Abstract]
Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011 Sep;70(3):410-7 [Abstract]
Handel A, Longini IM Jr, Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comp Biol 2007 Dec 7;3(12):e240 [Full text]
Hanley BP, Borup B. Aerosol influenza transmission risk contours: a study of humid tropics versus winter temperate zone. Virol J 2010 May 14;7:98 [Abstract]
Hao L, Sakurai A, Watanabe T, et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008 Aug 14;454(7206):890-3 [Abstract]
Hara M, Tanaka K, Kase T, et al. Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan. Vaccine 2010 Aug 9;28(35):5664-8 [Full text]
Hardelid P, Fleming DM, Andrews N, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. Vaccine 2011 (published online Dec 16) [Abstract]
Hardelid P, Fleming DM, McMenamin J, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1) 2009 infection in England and Scotland 2009-2010. Euro Surveill 2011 Jan 13;16(2):pii=19763 [Full text]
Harder KM, Molbak K, Glismann S, et al. Influenza-associated illness is an important contributor to febrile convulsions in Danish children. J Infect 2012 (published online Feb 2) [Abstract]
Hargadon KM, Zhou H, Albrecht RA, et al. MHC class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells. J Virol 2011 Nov;85(22):11955-63 [Abstract]
Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009 Apr 15;48(8):1003-32 [Abstract]
Harris A, Cardone G, Winkler DC, et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci 2006 Dec 12;103(50):19123-7 [Abstract]
Harris JR, Martin D, Lichiello P, et al. Community vaccinators in the workplace. (Letter) Emerg Infect Dis 2011 Jun;17(6):1134-5 [Full text]
Harris K, Ream R, Gao J, et al. Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus. Virol J 2011 May 21;8:251 [Abstract]
Harris KM, Maurer J, Kellermann AL. Influenza vaccine: safe, effective, and mistrusted. (Perspective) N Engl J Med 2010 Dec 2;363:2183-5 [Full text]
Harris KM, Maurer J, Lurie N. Is getting influenza vaccine coverage data out during mid-season feasible? Evidence from a national survey of US adults. Vaccine 2009 Jun 8;27(28):3697-9 [Abstract]
Harris KM, Schonlau M, Lurie N. Surveying a nationally representative internet-based panel to obtain timely estimates of influenza vaccination rates. Vaccine 2009 Feb 5;27(5):815-8 [Abstract]
Hassan F, Lewis TC, Davis MM, et al. Hospital utilization and costs among children with influenza, 2003. Am J Preventive Med 2009 Apr;36(4):292-6 [Abstract]
Hatakeyama S, Iwatsuki-Horimoto K, Okamoto K, et al. Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults. Vaccine 2011 Nov 15;29(49):9224-8 [Abstract]
Hatakeyama S, Sugaya N, Ito M, et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase. JAMA 2007 Apr 4;297(13):1435-42 [Abstract]
Hauge SH, Dudman S, Borgen K, et al. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 2009 Feb;15(2):155-62 [Full text]
Haviland AM, Elliott MN, Hambarsoomian K, et al. Immunization disparities by Hispanic ethnicity and language preference. Arch Intern Med 2011 Jan 24;171(2):158-65 [Abstract]
Hay AJ, Gregory V, Douglas AR, et al. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001 Dec 29;356(1416):1861-70 [Abstract]
Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004 Feb 1;189(3):440-9 [Abstract]
Hayden FG, de Jong MD. Emerging influenza antiviral resistance threats. (Editorial) J Infect Dis 2010 Jan 1;203(1):6-10 [Full text]
Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S119-26 [Abstract]
Haynes JR. Influenza virus-like particle vaccines. Expert Rev Vaccines 2009 Apr;8(4):435-45 [Abstract]
Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006 Dec 16;333(7581):1241 [Abstract]
Hayward JJ, Dubovi EJ, Scarlett JM, et al. Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States. J Virol 2010 Dec;84(24):12636-45 [Abstract]
Hedlund M, Aschenbrenner LM, Jensen K, et al. Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection. J Infect Dis 2010 Apr 1;201(7):1007-15 [Abstract]
Heikkinen T, Heinonen S. Effectiveness and safety of influenza vaccination in children: European perspective. Vaccine 2011 Oct 6;29(43):7529-34 [Abstract]
Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004 Oct 15;190(8):1369-73 [Abstract]
Heikkinen T, Ville P. Influenza vaccination of children. Lancet Infect Dis 2009 Dec;9(12):720-1 [Full text]
Heimbuch BK, Wallace WH, Kinney K, et al. A pandemic influenza preparedness study: use of energetic methods to decontaminate filtering facepiece respirators contaminated with H1N1 aerosols and droplets. Am J Infect Control 2011 Feb;39(1):e1-9 [Abstract]
Heininger U, Bachtiar NS, Bahri P, et al. The concept of vaccination failure. Vaccine 2011 (published online Dec 21) [Abstract]
Heinonen S, Peltola V, Silvennoinen H, et al. Signs and symptoms predicting influenza in children: a matched case-control analysis of prospectively collected clinical data. Eur J Clin Microbiol Infect Dis 2011 (published online Nov 13) [Abstract]
Heinonen S, Silvennoinen H, Lehtinen P, et al. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial. Clin Infect Dis 2010 Oct 15;51(8):887-94 [Full text]
Heinonen S, Silvennoinen H, Lehtinen P, et al. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011 Jan;11(1):23-9 [Abstract]
Heinonen S, Silvennoinen H, Lehtinen P, et al. Feasibility of diagnosing influenza within 24 hours of symptom onset in children 1-3 years of age. Eur J Clin Microbiol Infect Dis 2011 Mar;30(3):387-92 [Abstract]
Helms C, Polgreen P, Polgreen L, et al. Voluntary reporting of employee influenza vaccination rates by acute care hospitals in Iowa: the impact of a four year provider-based statewide performance improvement project. Vaccine 2011 Apr 18;29(18):3483-8 [Abstract]
Helms CM, Polgreen PM. Should influenza immunisation be mandatory for healthcare workers? Yes. (Head to Head) BMJ 2008 Oct 28;337:a2142 [Extract - also see Isaacs counterpoint below]
Henderson DA. Universal influenza vaccination: an optimal goal--but how and when? (Editorial) Biosecur Bioterror 2010 Sep;8(3):219-21 [Excerpt]
Hendriks J, Holleman M, de Boer O, et al. An international technology platform for influenza vaccines. Vaccine 2011 Jul 1;29(suppl 1):A8-11 [Abstract]
Hensley SE, Das SR, Bailey AL, et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009 Oct 30;326(5953):734-6 [Abstract]
Hensley SE, Das SR, Gibbs JS, et al. Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS ONE 2011 Feb 22;6(2):e15190 [Full text]
Herberg JA, Jones KDJ, Paulus S, et al. Comparison of pandemic and seasonal influenza reveals higher mortality and increased prevalence of shock in children with severe H1N1/09 infection. Pediatric Infect Dis J 2011 May;30(5):438-40 [Abstract]
Herlocher ML, Truscon R, Elias S, et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 2004 Nov 1;190(9):1627-30 [Abstract]
Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011 (published online Jun 15) [Abstract]
Heymann A, Chodick G, Reichman B, et al. Influence of school closure on the incidence of viral respiratory diseases among children and on health care utilization. Pediatr Infect Dis J 2004 Jul;23(7):675-7 [Abstract]
Hibbert CL, Piedra PA, McLaurin KK, et al. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine 2007 Nov 19;25(47):8010-20 [Abstract]
Higa F, Tateyama M, Tomishima M, et al. Role of neuraminidase inhibitor chemoprophylaxis in controlling nosocomial influenza: an observational study. Influenza Other Respi Viruses 2011 (published online Nov 26) [Abstract]
Hinshaw D, Chandran AU. Evaluation of a geriatric inpatient influenza immunization program. Am J Infect Control 2011 May;39(4):342-4 [Abstract]
Hirsch P, Hodgson M, Davey V. Seasonal influenza vaccination of healthcare employees: results of a 4-year campaign. Infect Control Hosp Epidemiol 2011 May;32(5):444-8 [Abstract]
Hoa YC, Wang JL, Wang JT, et al. Prognostic factors for fatal adult influenza pneumonia. J Infect 2009 Jun;58(6):439-45 [Abstract]
Hoft DF, Babusis E, Worku S, et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011 (published online Aug 15) [Abstract]
Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008 Sep 1;198(5):650-8 [Abstract]
Hollmeyer HG, Hayden F, Poland G, et al. Influenza vaccination of health care workers in hospitals - a review of studies on attitudes and predictors. Vaccine 2009 Jun 19;27(30):3935-44 [Abstract]
Holm MV, Blank PR, Szucs TD. Developments in influenza vaccination coverage in England, Scotland, and Wales covering five consecutive seasons from 2001 to 2006. Vaccine 2007 Nov 14;25(46):7931-8 [Abstract]
Holm MV, Blank PR, Szucs TD. Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infect Dis 2007 Dec 10;7:144 [Abstract]
Holmes EC, Ghedin E, Miller N, et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 2005 Sep;3(9):e300 [Full text]
Holmes EC. Helping the resistance. (Commentary) Science 2010 Jun 4;328(5983):1243-4 [Abstract]
Holodniy M, Penzak SR, Straight TM, et al. Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother 2008 Sep;52(9):3013-21 [Abstract]
Hoopes JD, Driebe EM, Kelley E, et al. Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus. PLoS ONE 2011 Dec 29;6(12):e29778 [Full text]
Hota S, McGeer A. Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007 Nov 15;45(10):1362-8 [Abstract]
Hotchkiss JR, Strike DG, Crooke PS. Pathogen transmission and clinic scheduling. Emerg Infect Dis 2005 Jan;12(1):159-62 [Full text]
Hottes TS, Skowronski DM, Hiebert B, et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS ONE 2011 Jul 26;6(7):e22618 [Full text]
Hourfar MK, Themann A, Eickmann M, et al. Blood screening for influenza. Emerg Infect Dis 2007 Jul;13(7):1081-3 [Full text]
Hsieh EF, Lin SJ, Mok CK, et al. Altered pathogenicity for seasonal influenza virus by single reassortment of the RNP genes derived from the 2009 pandemic influenza virus. J Infect Dis 2011 Sep 15;204(6):864-72 [Abstract]
Hsieh YH, Chen KF, Gaydos CA, et al. Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season. PLoS One 2010 Jan 28;5(1):e8945 [Full text]
Hsieh YH. Age groups and spread of influenza: implications for vaccination strategy. BMC Infect Dis 2010 Apr 30;10(1):106 [Abstract]
Huang FF, Barnes PF, Feng Y, et al. GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med 2011 Jul;184(2):259-68 [Abstract]
Huang PY, Huang CT, Tsao KC, et al. Syndromic recognition of influenza A infection in a low prevalence community setting. PLoS ONE 2010 May 7;5(5):e10542 [Full text]
Huang Y, Zaas AK, Rao A, et al. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza A infection. PLoS Genet 2011 Aug 25;7(8):e1002234 [Full text]
Hubby B, Talarico T, Maughan M, et al. Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine 2007 Nov 23;25(48):8180-9 [Abstract]
Huber VC, McCullers JA. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. J Infect Dis 2006 Mar 1;193(5):677-84 [Abstract]
Huleatt JW, Nakaar V, Desai P, et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 2008 Jan 10;26(2):201-14 [Abstract]
Hull HF, Frauendienst RS, Gundersen ML, et al. School-based influenza immunization. Vaccine 2008 Aug 12;26(34):4312-3 [Abstract]
Hulth A, Rydevik G, Linde A. Web queries as a source for syndromic surveillance. PLoS ONE 2009 Feb 6;4(2):e4378 [Abstract]
Humberd J, Guan Y, Webster RG. Comparison of the replication of influenza A viruses in Chinese ring-necked pheasants and Chukar partridges. J Virol 2006 Mar;80(5):2151-61 [Full text]
Hung IFN, Leung AYM, Chu DWS, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010 Nov 1;51(9):1007-16 [Full text]
Hurley LP, Wortley P, Allison MA, et al. Seasonal influenza vaccination in adults: practice and attitudes about collaborative delivery with community vaccinators. Vaccine 2011 Nov 3;29(47):8649-55 [Abstract]
Hurt AC, Ernest J, Deng YM, et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, southeast Asia, and South Africa. Antiviral Res 2009 Jul;83(1):90-3 [Abstract]
Hurt AC, Holien JK, Parker M, et al. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol 2009 Oct;83(20):10366-73 [Abstract]
Ichihashi T, Yoshida R, Sugimoto C, et al. Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model. PLoS ONE 2011 Sep 19;6(9):e24626 [Full text]
Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci 2011 Mar 29;108(13):5354-9 [Abstract]
IDSA (Infectious Diseases Society of America). Pandemic and seasonal influenza principles for US action. Released Jan 25, 2007 [Full text]
Ilyinskii PO, Gambaryan AS, Merlin AB, et al. Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency. PLoS ONE 2008 Jan 16;3(1):e1417 [Full text]
Ilyushina NA, Govorkova EA, Russell CJ, et al. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol 2007 Apr;88(4):1266-74 [Abstract]
Influenza team, ECDPC. Influenza transmission: research needs for informing infection control policies and practice. Eurosurveillance Weekly 2007 May 10;12(5):pii=3189 [Full text]
IOM (Institute of Medicine). Immunization safety review: vaccines and autism. Washington, DC: National Academies Press, 2004 [Full text]
Iorio A, Basileo M, Marcucci M, et al. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. Arch Intern Med 2010 Apr 12;170(7):609-16 [Abstract]
Ip M, Tang JW, Hui DSC, et al. Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. Am J Infect Control 2007 Dec;35(10):684-9 [Abstract]
Isaacs D, Leask J. Should influenza immunisation be mandatory for healthcare workers? No. (Head to Head) BMJ 2008 Oct 28;337:a2140 [Extract - also see Helms counterpoint above]
Ison MG, de Jong MD, Gilligan KJ, et al. End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. J Infect Dis 2010 Jun 1;201(11):1654-62 [Abstract]
Ison MG, Gubareva LV, Atmar RL, et al. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 2006 Mar 15;193(6):760-4 [Abstract]
Ison MG, Mishin V, Braciale TJ, et al. Comparative activities of oseltamivir and A-322278 in immunocompetent and immnocompromised murine models of influenza virus infection. J Infect Dis 2006 Mar 15;193(6):765-72 [Abstract]
Ison MG. Influenza in hospitalized adults: gaining insight into a significant problem. (Editorial commentary) J Infect Dis 2009 Aug 15;200(4):485-8 [Full text]
Iwane MK, Singleton JA, Walton K, et al. Assessing influenza vaccine utilization in physician offices serving adult patients: experience during a season of vaccine delays and shortages. J Public Health Manag Pract 2007 May/Jun;13(3):307-13 [Abstract]
Iyer SB, Gerber MA, Pomerantz WJ, et al. Effect of point-of-care influenza testing on management of febrile children. Acad Emerg Med 2006 Dec;13(12):1259-68 [Abstract]
Izurieta HS, Haber P, Wise RP, et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005 Dec 7;294(21):2720-5 [Abstract]
Jackson LA, Gaglani MJ, Keyserling HL, et al. Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis 2010 Mar 17;10(1):71 [Abstract]
Jackson LA, Neuzil KM, Baggs J, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics 2006 Nov;118(5):2032-7 [Abstract]
Jackson LA, Patel SM, Swamy GK, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011 Sep 15;204(6):854-63 [Abstract]
Jackson LA. Using surveillance to evaluate influenza vaccine effectiveness. (Editorial commentary) J Infect Dis 2009 Jan 15;199(2):155-8 [Full text]
Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008 Aug 2;372(9636):398-405 [Abstract]
Jackson RJ, Cooper KL, Tappenden P, et al. Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review. J Infect 2011 Jan;62(1):14-25 [Abstract]
Jackson S, Van Hoeven N, Chen LM, et al. Reassortant between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment. J Virol 2009 Aug;83(16):8131-40 [Abstract]
Jafri HS, Ramilo O, Makari D, et al. Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey. Ped Infect Dis J 2007 Oct;26(10):956-8 [Abstract]
Jain S, Chaves SS. Obesity and influenza. (Commentary) Clin Infect Dis 2011 Sep 1;53(5):422-4 [Full text]
Janies DA, Voronkin IO, Studer J, et al. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages. Int J Health Geogr 2010 Feb 24;9(1):13 [Abstract]
Janjua NZ, Skowronski DM, Hottes TS, et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010 Nov 1;51(9):1017-27 [Abstract]
Jayasekera JP, Moseman EA, Carrol MC. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 2007 Apr;81(7):3487-94 [Abstract]
Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006 Jan 28;367(9507):303-13 [Abstract]
Jefferson T, DiPietrantonj C, Debalini MG, et al. Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review. BMJ 2009 Feb 12;338:b354 [Abstract]
Jefferson T, Foxlee R, Del Mar C, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2007 Oct 17;(4):CD006207 [Abstract]
Jefferson T, Jones M, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009 Dec 8;339:b5106 [Full text]
Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2012 Jan 18;(1):CD008965 [Full text]
Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005 Oct 1;366(9492):1165-74 [Abstract]
Jefferson T, Smith S, Demicheli V, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005 Feb 26-Mar 4;365(9461):773-80. [Abstract]
Jefferson T. Influenza vaccination: policy versus evidence. (Analysis and comment) BMJ 2006 Oct 28;333(7574):912-5 [Abstract]
Jenlink CH, Kuehnert P, Mazyck D. H1N1 vaccinations, fall 2009: model school-located vaccination clinics. J Sch Nurs 2010 Aug;26(4 Suppl):7S-13 [Abstract]
Jennings LC, Skopnik H, Burckhardt I, et al. Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza Other Resp Viruses 2009 May;3(3):91-98 [Abstract]
Jeong EK, Bae JE, Kim IS. Inactivation of influenza A virus H1N1 by disinfection process. Am J Infect control 2010 Jun;38(5):354-60 [Abstract]
Jewell NA, Cline T, Mertz SE, et al. Interferon-lambda is the predominant interferon induced by influenza A virus infection in vivo. J Virol 2010 Nov;84(21):11515-22 [Abstract]
Jhee SS, Yen M, Ereshefsky L, et al. Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid of healthy Japanese and Caucasian volunteers. Antimicrobial Agents Chemother 2008 Oct;52(10):3687-93 [Abstract]
Jian JW, Chen GW, Lai CT, et al. Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. J Clin Microbiol 2008 Apr;46(4);1426-34 [Abstract]
Jimenez-Garcia R, Carrasco-Garrido P, Hernandez-Barrera V, et al. Estimates of influenza vaccination target population sizes in Spain for the 2006-2007 season. Vaccine 2007 Apr 30;25(17):3249-53 [Abstract]
Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, et al. Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006. J Infect 2008 Dec;57(6):472-80 [Abstract]
Jimenez-Garcia R, Hernandez-Barrera V, Lopez de Andres A, et al. Gender influence in influenza vaccine uptake in Spain: time trends analysis (1995-2006). Vaccine 2010 Aug 31;28(38):6169-75 [Abstract]
Jimenez-Garcia R, Rodriguez-Rieiro C, Hernandez-Barrera V, et al. Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain). Vaccine 2011 Apr 5;29(16):2840-5 [Abstract]
Jit M, Cromer D, Baguelin M, et al. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine 2010 Dec 10;29(1):115-22 [Abstract]
Jo YM, Song JY, Hwang IS, et al. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. J Med Virol 2009 Feb 23;81(4):722-7 [Abstract]
Johansson BE, Brett IC. Changing perspective on immunization against influenza. Vaccine 2007 Apr 20;25(16):3062-5 [Abstract]
Johns MC, Eick AA, Blazes DL, et al. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS ONE 2010 May 19;5(5):e10722 [Full text]
Johnson DF, Druce JD, Birch C, et al. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. (Brief report) Clin Infect Dis 2009 Jul 15;49(2):275-7 [Abstract]
Jones S, Evans K, McElwaine-John H, et al. DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b trial. Vaccine 2009 Apr 21;27(18):2506-2512 [Abstract]
Jones TF, Ingram LA, Craig AS, et al. Determinants of influenza vaccination, 2003-2004: shortages, fallacies and disparities. Clin Infect Dis 2004 Dec 15;39(12):1824-8 [Abstract]
Jordan R, Olowokure B. Indirect community protection against influenza by vaccinating children: a review of two recent studies from Italy and the United States. Euro Surveill 2004 Dec 16;8(51):pii=2605 [Full text]
Josset L, Textoris J, Loriod B, et al. Gene expression signature-based screening identifies new broadly effective influenza A antivirals. PLoS ONE 2010 Oct 4;5(10):e13169 [Full text]
Juurlink DN, Stukel TA, Kwong J, et al. Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006 Nov 13;166(20):2217-21 [Abstract]
Juzeniene A, Ma LW, Kwitniewski M, et al. The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D. Int J Infect Dis 2010 Dec;14(12):e1099-105 [Abstract]
Kammerer PE, Montiel S, Kriner P, et al. Influenza-like illness surveillance on the California-Mexico border, 2004-2009. Influenza Other Respi Viruses 2011 (published online Dec 30) [Abstract]
Kanai Y, Boonsathorn N, Chittaganpitch M, et al. The impact of antigenic drift of influenza A virus on human herd immunity: sero-epidemiological study of H1N1 in healthy Thai population. Vaccine 2010 Jul 26;28(33):5437-44 [Abstract]
Kansagra SM, McGinty MD, Morgenthau BM, et al. Cost comparison of 2 mass vaccination campaigns against influenza A H1N1 in New York City. Am J Public Health 2011 (published online Dec 15) [Abstract]
Kao RY, Yang D, Lau LS, et al. Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol 2010 Jun;28(6):600-5 [Abstract]
Kappes MA, Sandbulte MR, Platt R, et al. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 2012 Jan 5;30(2):280-8 [Abstract]
Karlas A, Machuy N, Shin Y, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. (Letter) Nature 2010 Feb 11;463:818-22 [Full text]
Kasper MR, Wierzba TF, Sovann L, et al. Evaluation of an influenza-like illness case definition in the diagnosis of influenza among patients with acute febrile illness in Cambodia. BMC Infect Dis 2010 Nov 7;10:320 [Abstract]
Katayose M, Hosoya M, Haneda T, et al. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons. Vaccine 2010 Feb 17;29(9):1844-9 [Abstract]
Katz MA, Tharmaphornpilas P, Chantra S, et al. Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy. Vaccine 2007 May 10;25(19):3827-33 [Abstract]
Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006 Aug 15;43(4):439-44 [Full text]
Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. J Infect 2008 Jan;56(1):51-7 [Abstract]
Kawai N, Ikematsu H, Iwaki N, et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan on the 2002-2003 influenza season. Clin Infect Dis 2005 May 1;40(9):1309-16 [Abstract]
Kawai N, Ikematsu H, Iwaki N, et al. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 2007 Sep;55(3):267-72 [Abstract]
Kawai S, Nanri S, Ban E, et al. Influenza vaccination of schoolchildren and influenza outbreaks in a school. Clin Infect Dis 2011 Jul 15;52(2):130-6 [Abstract]
Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 2008;26(11):911-24 [Abstract]
Keijzers GB, Vossen CNKL, Zhang P, et al. Predicting influenza A and 2009 H1N1 influenza in patients admitted to hospital with acute respiratory illness. Emerg Med J 2011 (published online Mar 25) [Abstract]
Keitel WA, Atmar RL, Cate TR, et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 2006 May 22;166(1):1121-7 [Abstract]
Keitel WA, Atmar RL, Nino D, et al. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different variants. J Infect Dis 2008 Oct 1;198(7):1016-8 [Abstract]
Kelly H, Barry S, Laurie K, et al. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Euro Surveill 2010 Nov 25;15(47):pii=19722 [Full text]
Kelly H, Carcione D, Dowse G, et al. Authors' reply: benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children. (Letter reply) Euro Surveill 2010 Oct 7;15(40):pii=19681 [Full text; see Lopert R, below, for letter]
Kelly H, Carcione D, Dowse G, et al. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010. Euro Surveill 2010 Sep 16;15(37):pii=19661 [Full text]
Kelly H, Carville K, Grant K, et al. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS ONE 2009 Mar 31;4(3):e5079 [Full text]
Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. (Rapid communications) Eurosurveill 2009 Aug 6;14(31):pii=19288 [Full text]
Kelly H, Valenciano M. Estimating the effect of influenza vaccines. (Commentary) Lancet Infect Dis 2012 Jan;12(1):5-6 [Extract]
Kelly HA, Grant KA, Fielding JE, et al. Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 2011 Aug 26;29(37):6419-26 [Abstract]
Kelly HA, Skowronski DM, De Serres G, et al. Adverse events associated with 2010 CSL and other inactivated influenza vaccines. (Perspective). Med J Aust 2011 Sep 19;195(6):318-20 [Abstract]
Kenah E, Chao DL, Matrajt L, et al. The global transmission and control of influenza. PLoS ONE 2011 May 6;6(5):e19515 [Full text]
Kenney RT, Frech SA, Muenz L, et al. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004 Nov 25;351(22):2295-2301 [Full text]
Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005 Nov 2;294(17):2182-7 [Abstract]
Keren R, Zaoutis TE, Saddlemire S, et al. Direct medical cost of influenza-related hospitalizations in children. Pediatrics 2006 Nov;118(5):1321-7 [Abstract]
Khandaker G, Lester-Smith D, Zurynski Y, et al. Pandemic (H1N1) 2009 and seasonal influenza A (H3N2) in children's hospital, Australia. (Letter) Emerg Infect Dis 2011 Oct;17(10):1960-2 [Full text]
Kharbanda EO, Vargas CY, Castano PM, et al. Exploring pregnant women's views on influenza vaccination and educational text messages. Prev Med 2011 Jan;52(1):75-7 [Abstract]
Khazeni N, Bravata DM, Holty JEC, et al. Safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med 2009 Oct 6;151(7):464-73 [Full text]
Khiabanian H, Farrell GM, St George K, et al. Differences in patient age distribution between influenza A subtypes. PLoS ONE 2009 Aug 31;4(8):e6832 [Full text]
Kidd F, Wones R, Momper A, et al. From 51% to 100%: mandatory seasonal influenza vaccination. Am J Infect Control 2011 (published online Jul 18) [Abstract]
Kilbourne ED. What are the prospects for a universal influenza vaccine? Nat Med 1999 Oct;5(10):1119-20 [Full text]
Killingley B, Enstone J, Booy R, et al. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect Dis 2011 Nov;11(11):879-86 [Full text]
Kim YH, Kim HS, Cho SH, et al. Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus. Viral Immunol 2009 Dec;22(6):423-30 [Abstract]
Kimura AC, Nguyen CN, Higa JI, et al. The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities. Am J Pub Health 2007 Apr;97(4):684-90 [Abstract]
King JC Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006 Dec 14;355(24):2523-32 [Full text]
King JC, Beckett D, Snyder J, et al. Direct and indirect impact of influenza vaccination of young children on school absenteeism. Vaccine 2012 Jan 5;30(2):289-93 [Abstract]
King Jr JC, Lichenstein R, Cummings GE, et al. Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland. Vaccine 2010 Nov 16;28(49):7737-42 [Abstract]
Kirkland PD, Finlaison DS, Crispe E, et al. Influenza virus transmission from horses to dogs, Australia. Emerg Infect Dis 2010 Apr;16(4):699-702 [Full text]
Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004 Aug 28;364(9436):759-65 [Abstract]
Kissling E, Valenciano M, I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Euro Surveill 2011 Mar 17;16(11):pii=19818 [Full text]
Klick B, Leung GM, Cowling BJ. Optimal design of studies of influenza transmission in households: I: case-ascertained studies. Epidemiol Infect 2012 Jan;140(1):106-14 [Abstract]
Knibbs LD, Morawaska L, Bell SC. The risk of airborne influenza transmission in passenger cars. Epidemiol Infect 2011 (published online May 9) [Abstract]
Knibbs LD, Morawska L, Bell SC, et al. Room ventilation and the risk of airborne infection transmission in 3 health care settings within a large teaching hospital. Am J Infect Control 2011 Dec;39(10):866-72 [Abstract]
Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007 Jul;81(13):7011-21 [Abstract]
Koelle K, Cobey S, Grenfell B, et al. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 2006 Dec 22;314(5807):1898-903 [Abstract]
Koelle K, Khatri P, Kamradt M, et al. A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza. J R Soc Interface 2010 Sep 6;7(50):1257-74 [Abstract]
Koerner I, Kochs G, Kalinke U. et al. Protective role of beta interferon in host defense against influenza A virus. J Virol 2007 Feb;81(4):2025-30 [Abstract]
Kohno S, Kida H, Mizuguchi M, et al. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother 2010 Nov;54(11):4568-74 [Abstract]
Kok G, van Essen GA, Wicker S, et al. Planning for influenza vaccination in health care workers: an intervention mapping approach. Vaccine 2011 Nov 3;29(47):8512-9 [Abstract]
Kong WL, Huang LZ, Qi HT, et al. Genetic characterization of H1N2 influenza A viruses isolated from sick pigs in southern China in 2010. Virol J 2011 Oct 13;8:469 [Abstract]
Koonin LM, Cetron MS. School closure to reduce influenza transmission. (Letter) Emerg Infect Dis 2009 Jan;15(1):137-9 [Full text]
Kornish LJ, Keeney RL. Repeated commit-or-defer decisions with a deadline: the influenza vaccine composition. Operations Res 2008 May-Jun;56(3):527-41 [Full text]
Kosalaraksa P, Srirompotong U, Newman RW, et al. Serological response to trivalent inactive influenza vaccine in HIV-infected children with different immunologic status. Vaccine 2011 Apr 5;29(16):3055-60 [Abstract]
Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, et al. Transdermal influenza immunization with vaccine coated microneedle arrays. PLoS ONE 2009 Mar 10;4(3):e4773 [Full text]
Kramarz P, Monnet D, Nicoll A, et al. Use of oseltamivir in 12 European countries between 2002 and 2007 - lack of association with the appearance of oseltamivir-resistant influenza A (H1N1) viruses. Eurosurveill 2009 Feb 5;14(5):pii=19112 [Abstract]
Krasnitz M, Levine AJ, Rabadan R. Anomalies in the influenza virus genome database: new biology or laboratory errors? J Virol 2008 Sep;82(17):8947-50 [Abstract]
Kraut A, Graff L, McLean D. Behavioral change with influenza vaccination: factors influencing increased uptake of the pandemic H1N1 versus seasonal influenza vaccine in health care personnel. Vaccine 2011 Oct 26;29(46):8357-63 [Abstract]
Kreijtz JH, Bodewes R, van Amerongen G, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007 Jan 8;25(4):612-20 [Abstract]
Kroneman M, Paget WJ, Meuwissen LE, et al. An approach to monitoring influenza vaccination uptake across Europe. Eurosurveillance 2008 May 15;13(20):pii=18874 [Full text]
Kroneman MW, van Essen GA. Stagnating influenza vaccine coverage rates among high-risk groups in Poland and Sweden in 2003/4 and 2004/5. Eurosurveillance Monthly 2007 Apr;12(4):pii=696 [Full text]
Krumbholz A, Schmidtke M, Bergmann S, et al. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J Gen Virol 2009 Apr;90(4):900-8 [Abstract]
Kryazhimskiy S, Dieckmann U, Levin SA, et al. On state-space reduction in multi-strain pathogen models, with an application to antigenic drift in influenza A. PLoS Comput Biol 2007 Aug;3(8):e159 [Full text]
Kryazhimskiy S, Dushoff J, Bazykin GA, et al. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet 2011 Feb 17;7(2):e1001301 [Full text]
Kucharski A, Gog JR. Influenza emergence in the face of evolutionary constraints. Proc R Soc Med 2011 (published online Jul 20) [Abstract]
Kugel D, Kochs G, Obojes K, et al. Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol 2009 Apr 15;83(8):3843-51 [Abstract]
Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008 Sep 12;26(suppl 4):D59-66 [Full text]
Kuntz JL, Holley S, Helms CM, et al. Use of a pandemic preparedness drill to increase rates of influenza vaccination among healthcare workers. Infect Control Hosp Epidemiol 2008 Feb;29(2):111-5 [Abstract]
Kuster SP, Drews S, Green K, et al. Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8. Eur J Clin Microbiol Infect Dis 2010 Jul 20;29(7):835-43 [Abstract]
Kuster SP, Shah PS, Coleman BL, et al. Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PLoS ONE 2011 Oct 18;6(10):e26239 [Full text]
Kuster SP, Tuite AR, Kwong JC, et al. Evaluation of coseasonality of influenza and invasive pneumococcal disease: results from prospective surveillance. PLoS Med 2011 Jun 7;8(6):e1001042 [Full text]
Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011 Sep 1;53(5):413-21 [Abstract]
Kwong JC, Li P, Redelmeier DA. Influenza morbidity and mortality in elderly patients receiving statins: a cohort study. PLoS One 2009 Nov 30;4(11):8087 [Full text]
Kwong JC, Rosella LC, Johansen H. Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Rep 2007 Nov;18(4):9-19 (released Oct 2) [Abstract]
Kwong JC, Stukel TA, Lim J, et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008 Oct 28;5(10):e211 [Full text]
La Montagne JR, Fauci AS. Intradermal influenza vaccination--can less be more? (Editorial) N Engl J Med 2004 Nov 25;351(22):2230-2 [Full text]
La Torre G, Larocci G, Cadeddu C, et al. Influence of sociodemographic inequalities and chronic conditions on influenza vaccination coverage in Italy: results from a survey in the general population. Public Health 2010 Dec;124(12):690-7 [Full text]
Lackenby A, Hungnes O, Dudman SG, et al. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Eurosurveillance Weekly 2008 Jan 31;13(5):pii=8026 [Full text]
Lackenby A, Thompson CI, Democratis J. The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 2008 Dec;21(6):626-38 [Abstract]
Lafeber RABVG, Riesmeijer RM, Friesema IHM, et al. Case-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009-2010 pandemic season versus the 2010-2011 influenza season. BMC Public Health 2011 Oct 4;11:758 [Abstract]
Laguna-Torres VA, Gomez J, Aguilar PV, et al. Changes in the viral distribution pattern after the appearance of the novel influenza A H1N1 (pH1N1) virus in influenza-like illness patients in Peru. PLoS ONE 2010 Jul 27;5(7):e11719 [Full text]
Lam PP, Chambers LW, MacDougall DMP. Seasonal influenza vaccination campaigns for health personnel: systematic review. CMAJ 2010 Sep 7;182(12):e542-8 [Abstract]
Langley JM, Aoki F, Ward BJ, et al. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Vaccine 2011 Feb 24;29(10):1921-8 [Abstract]
Langley JM. Release of the statement on influenza for the 2007-2008 season from the National Advisory Committee on Immunization. CMAJ 2007 Oct 23;177(9):1025-6 [Full text]
Laplante JM, Marshall SA, Shudt M, et al. Influenza antiviral resistance testing in New York and Wisconsin, 2006-2008: methodology and surveillance data. J Clin Microbiol 2009 May;47(5):1372-8 [Abstract]
Lasserson T, Tovey D. Neuraminidase inhibitors for influenza: methods change, principles don't. (Editorial) Cochrane Library 2012 Jan 18 [Full text]
Lau EHY, Cowling BJ, Ho LM, et al. Optimizing use of multistream influenza sentinel surveillance data. Emerg Infect Dis 2008 Jul;14(7):1154-7 [Full text]
Lau JTF, Cai Y, Tsui HY, et al. Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong. Vaccine 2010 Jul 26;28(33):5389-97 [Abstract]
Lau LLH, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010 May 15;201(10):1509-16 [Full text]
Laurie KL, Carolan LA, Middleton D, et al. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis 2010 Oct 1;202(7):1011-20 [Abstract]
LaVela SL, Smith B, Weaver FM, et al. Attitudes and practices regarding influenza vaccination among healthcare workers providing services to individuals with spinal cord injuries and disorders. Infect Control Hosp Epidemiol 2004 Dec;25(11):933-40 [Abstract]
Layne SP. Human influenza surveillance: the demand to expand. Emerg Infect Dis 2006 Apr;12(4):562-8 [Full text]
Leckerman KH, Sherman E, Knorr J, et al. Risk factors for healthcare-associated, laboratory-confirmed influenza in hospitalized pediatric patients: a case-control study. Infect Control Hosp Epidemiol 2010 Apr;31(4):421-4 [Abstract]
Lee BE, Mukhi SN, Drews SJ. Association between patient age and influenza A subtype during influenza outbreaks. Infect Control Hosp Epidemiol 2010 May;31(5):535-7 [Abstract]
Lee BY, Bacon K, Donohue JM, et al. From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine 2011 Mar 3;29(11):2149-58 [Abstract]
Lee BY, Bailey RR, Wiringa AE, et al. Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine 2010 Aug 23;28(37):5952-9 [Abstract]
Lee BY, Brown ST, Bailey RR, et al. The benefits to all of ensuring equal and timely access to influenza vaccines in poor communities. Health Aff 2011 Jun;30(6):1141-50 [Abstract]
Lee BY, McGlone SM, Bailey RR, et al. To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling. PLoS ONE 2010 Jun 23;5(6):e11284 [Full text]
Lee BY, Mehrotra A, Burns RM, et al. Alternative vaccination locations: who uses them and can they increase flu vaccination rates? (Short communication) Vaccine 2009 Jul 9;27(32):4252-56 [Abstract]
Lee CK, Lee HK, Loh TP, et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza viral loads, Singapore. Emerg Infect Dis 2011 Feb;17(2):287-91 [Full text]
Lee GM, Greene SK, Weintraub ES, et al. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink Project. Am J Prev Med 2011 (published online Jul 5) [Full text]
Lee HK, Lee CK, Loh TP, et al. Missed diagnosis of influenza B virus due to nucleoprotein sequence mutations, Singapore, April 2011. Euro Surveill 2011 Aug 18;16(33):pii=19943 [Full text]
Lee LHW, Ha DLA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008 Oct 1;118(10):3478-90 [Full text]
Lee MS, Chen JSE. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 2004 Aug;10(8):1385-90 [Full text]
Lee MS, Chen MC, Liao YC, et al. Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine 2007 Nov 23;25(48):8133-9 [Abstract]
Lee N, Chan PKS, Hui DSC, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009 Aug 15;200(4):492-500 [Full text]
Lee RTC, Santos CLS, de Paiva TM, et al. All that glitters is not gold -- founder effects complicate associations of flu mutations to disease severity. Virol J 2010 Nov 1;7:297 [Abstract]
Lee SMY, Gardy JL, Cheung CY, et al. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 2009 Dec 14;4(12):e8072 [Full text]
Lee TH. Rationing influenza vaccine. N Engl J Med 2004 Dec 2;351(23):2365-6 [Extract]
Lee VJ, Chen MI, Yap J, et al. Comparability of different methods for estimating influenza infection rates over a single epidemic wave. Am J Epidemiol 2011 Aug 15;174(4):468-78 [Abstract]
Lee VJ, Tay JK, Chen MIC, et al. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 2010 Oct 4;28(42):6852-7 [Abstract]
Lee VJ, Yap J, Cook AR, et al. A clinical diagnostic model for predicting influenza among young adult military personnel with febrile respiratory illness in Singapore. PLoS ONE 2011 Mar 2;6(3): e17468 [Full text]
Lee YN, Lee HJ, Lee DH, et al. Severe canine influenza in dogs correlates with hyperchemokinemia and high viral load. Virology 2011 Aug 15;417(1):57-63 [Abstract]
Leeb A, Carcione D, Richmond PC, et al. Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults. Vaccine 2011 Oct 19;29(45):7920-4 [Abstract]
Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007 Sep;28(9):1071-6 [Abstract]
Lemaitre M, Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 2010 Jun 9;10(1):162 [Abstract]
Lemay R, Mawudeku A, Shi Y, et al. Syndromic surveillance for influenzalike illness. Biosecur Bioterror 2008 Jun;6(2):161-70 [Abstract]
Lemieux C, Brankston G, Gitterman L, et al. Questioning aerosol transmission of influenza. (Letter) Emerg Infect Dis 2007 Jan;13(1):173-4 [Full text]
Lenschow DJ, Lai C, Frias-Staheli N, et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci 2007 Jan 23;104(4):1371-6 [Abstract]
Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 2008 Dec 2;26(51):6614-9 [Abstract]
Lessler J, Reich NG, Brookmeyer R, et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009 May;9(5):291-300 [Abstract]
Lewis EN, Griffin MR, Szilagyi PG, et al. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 2007 Sep;120(3):467-72 [Abstract]
Li D, Saito R, Le MTQ, et al. Genetic analysis of influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006. J Clin Microbiol 2008 Feb;46(2):399-405 [Abstract]
Li W, Liu Y, Mukhtar MM, et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLos ONE 2008 Apr 16;3(4):e1985 [Full text]
Li YC. Absence of influenza vaccination among high-risk older adults in Taiwan. BMC Public Health 2010 Oct 13;10:603 [Abstract]
Li Z, Doan Q, Dobson S. Determinants of influenza immunization uptake in Canadian youths. Vaccine 2010 Apr 26;28(19):3462-6 [Full text]
Liao YC, Chen FC, Hsiung CA. Contrasting substitution patterns between HA proteins of avian and human influenza viruses: implication for monitoring human influenza epidemics. Vaccine 2010 Nov 23;28(50):7890-6 [Abstract]
Liljeqvist GTH, Staff M, Puech M, et al. Automated data extraction from general practice records in an Australian setting: trends in influenza-like illness in sentinel general practices and emergency departments. BMC Public Health 2011 Jun 6;11:435 [Abstract]
Lin CJ, Nowalk MP, Toback SL, et al. Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults. Vaccine 2010 Nov 10;28(48):7706-12 [Abstract]
Lin JH, Chiu SC, Le CH, et al. Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006-2007 season in Taiwan. J Med Virol 2008 Feb;80(2):316-22 [Abstract]
Lin JH, Tseng CP, Chen YJ, et al. Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis. J Clin Microbiol 2008 Mar;46(3):1090-7 [Abstract]
Lina B, Bouscambert M, Enouf V, et al. S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill 2011 Dec 15;16(50):pii=20039 [Full text]
Lindley MC, Groom AV, Wortley PM, et al. Status of influenza and pneumococcal vaccination among older American Indians and Alaska natives. Am J Public Health 2008 May;98(5):932-8 [Abstract]
Lindsley WG, Blachere FM, Davis KA, et al. Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis 2010 Mar 1;50(5):693-8 [Abstract]
Lindsley WG, Blachere FM, Thewlis RE, et al. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS ONE 2010 Nov 30;5(11):e15100 [Full text]
Linhart Y, Shohat T, Bromberg M, et al. Excess mortality from seasonal influenza is negligible below the age of 50 in Israel: implications for vaccine policy. Infection 2011 Oct;39(5):399-404 [Abstract]
Lipatov AS, Govorkova EA, Webby RJ, et al. Influenza: emergency and control. J Virol 2004 Sep 1;78(17):8951-9 [Full text]
Liu Q, Ma J, Liu H, et al. Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States. Arch Virol 2011 (published online Dec 23) [Abstract]
Liu S, Ji K, Chen J, et al. Panorama phylogenetic diversity and distribution of type A influenza virus. PLoS ONE 2009 Mar 27;4(3):e5022 [Full text]
Llupia A, Garcia-Basteiro AL, Olive V, et al. New interventions to increase influenza vaccination rates in health care workers. Am J Infect Control 2010 Aug;38(6):476-81 [Abstract]
Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009 Nov 4;302(17):1865-71 [Full text]
Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010 Mar 10;303(10):943-50 [Full text]
Loebermann M, Anders G, Brestrich G, et al. Safety and immunogenicity of a trivalent single does seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study. Vaccine 2011 Feb 1;29(6):1228-34 [Abstract]
Lofgren E, Fefferman NH, Naumov YN, et al. Influenza seasonality: underlying causes and modeling theories. J Virol 2007 Jun;81(11):5429-36 [Abstract]
Long BR, Michaelsson J, Loo CP, et al. Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin Vaccine Immunol 2008 Jan;15(1):120-30 [Abstract]
Long J, Bushnell RV, Tobin JK, et al. Evolution of H3N2 influenza virus in a guinea pig model. PLoS ONE 2011 Jul 22;6(7):e20130 [Full text]
Longini IM, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. (Commentary) Am J Epidemiol 2005 Feb 15;161(4):303-6 [Abstract]
Look JL, Butler B, Al-Khalili M, et al. The adjuvant patch: a universal dose sparing approach for pandemic and conventional vaccines. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]
Lopalco PL, Giesecke. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe. Eurosurveillance Weekly 2007 Jan 18;12(3):pii=3114 [Full text]
Lopert R. Benefit and risks of trivalent 2010 seasonal influenza vaccine in Australian children. (Letter) Euro Surveill 2010 Oct 7;15(40):pii=19679 [Full text; see Kelly H, above, for response]
Loving CL, Brockmeier SL, Vincent AL, et al. Influenza virus coinfection with Bordetella bronchiseptica enhances bacterial colonization and host responses exacerbating pulmonary lesions. Microb Pathog 2010 Nov;49(5):237-45 [Abstract]
Low D. Reducing antibiotic use in influenza: challenges and rewards. Clin Microbiol Infect 2008 Apr;14(4):298-306 [Abstract]
Lowen AC, Mubareka S, Steel J, et al. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 2007 Oct 19;3(10):e151 [Full text]
Lowen AC, Steel J, Mubareka S, et al. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol 2009 Apr;83(7):2803-18 [Abstract]
Lowen AC, Steel J, Mubareka S, et al. High temperature (30 deg C) blocks aerosol but not contact transmission of influenza virus. J Virol 2008 Jun;82(11):5650-2 [Abstract]
Lu B, Zhou H, Ye D, et al. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase acctivities. J Virol 2005 Jun 1;79(11):6763-71 [Abstract]
Lu P, Bridges CB, Euler GL, et al. Influenza vaccination of recommended adult populations, US, 1989-2005. Vaccine 2008 Mar 25;26(14):1786-93 [Abstract]
Lu PJ, Euler GL, Callahan DB. Influenza vaccination among adults with asthma: findings from the 2007 BRFSS survey. Am J Prevent Med 2009 Aug;37(2) (published online Jun 16) [Full text]
Lu PJ, Euler GL. Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States. Am J Infect Control 2011 Aug;39(6):488-94 [Abstract]
Luce BR, Nichol KL, Belshe RB, et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Vaccine 2008 June 2;26(33):2841-8 [Abstract]
Lugo NR. Will carrots or sticks raise influenza immunization rates of health care personnel? Am J Infect Control 2007 Feb;35(1):1-6 [Abstract]
Luna LK, Panning M, Grywna K, et al. Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis 2007 Mar 1;195(5):675-9 [Abstract]
Ma W, Vincent AL, Gramer MR, et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci 2007 Dec 26;104(52):20949-54 [Abstract]
MacInnes H, Zhour Y, Gouveia K, et al. Transmission of aerosolized seasonal H1N1 influenza A to ferrets. PLoS ONE 2011 Sep 19;6(9):e24448 [Full text]
MacIntyre CR, Cauchemez S, Dwyer DE, et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis 2009 Feb;15(2):233 [Full text]
Madjid M, Casscells SW. Of birds and men: cardiologists' role in influenza pandemics. (Letter) Lancet 2004 Oct 9;364(9442):1309 [Full text]
Madjid M, Lillibridge S, Mirhaji P, et al. Influenza as a bioweapon. J R Soc Med 2003;96(7):345-6 [Abstract]
Madjid M, Mikller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007 May;28(10):1205-10 [Abstract]
Maeda Y, Hatta M, Takada A, et al. Live bivalent vaccine for parainfluenza and influenza virus infections. J Virol 2005 Jun 1;79(11):6674-9 [Abstract]
Maines TR, Belser JA, Gustin KM, et al. Local innate immune responses and influenza virus transmission and virulence in ferrets. J Infect Dis 2011 (published online Dec 9) [Abstract]
Mak TK, Mangtani P, Leese J, et al. Influenza vaccination in pregnancy: Current evidence and selected national policies. Lancet Infect Dis 2008 Jan;8(1):44-52 [Abstract]
Mall S, Buchholz U, Tibussek D, et al. A large outbreak of influenza B-associated benign acute childhood myositis in Germany, 2007/2008. Pediatr Infect Dis J 2011 Aug;30(8):e142-6 [Abstract]
Malone JL, Madjid M, Casscells SW. Telephone survey to assess influenza-like illness, United States, 2006. Emerg Infect Dis 2008 Jan;14(1):129-35 [Full text]
Mangtani P, Cumberland P, Hodgson CR, et al. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom General Practice Research Database. J Infect Dis 2004 Jul 1;190(1):1-10 [Abstract]
Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007 Jan;135(1):139-45 [Abstract]
Mann P, O'Connell E, Zhang G, et al. Alert system to detect possible school-based outbreaks of influenza-like illness. Emerg Infect Dis 2011 Feb;17(2):262-4 [Full text]
Mao L. Evaluating the combined effectiveness of influenza control strategies and human preventive behavior. PLoS ONE 2011 Oct 17;6(10):e24706 [Full text]
Marcelin G, Bland HM, Negovetich NJ, et al. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-depedent manner. J Infect Dis 2010 Dec 1;202(11):1634-8 [Abstract]
Marcus PI, Ngunjiri JM, Sekellick MJ, et al. In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines. J Virol 2010 Nov;84(21):10974-81 [Abstract]
Marsden-Haug N, Foster VB, Gould PL, et al. Code-based syndromic surveillance for influenzalike illness by International Classification of Diseases, Ninth Revision. Emerg Infect Dis 2007 Feb;13(2):207-16 [Full text]
Marti F, Steffen R, Mutsch M. Influenza vaccine: a travelers' vaccine. Exp Rev Vaccines 2008 Jul;7(5):679-687 [Abstract]
Martina BEE, van den Doel P, Koraka P, et al. A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus. PLoS ONE 2011 Apr 26;6(4):e18995 [Full text]
Matrajt L, Longini IM. Optimizing vaccine allocation at different points in time during an epidemic. PLoS ONE 2010 Nov 11;5(11):e13767 [Full text]
Matsui T, Hakozaki Y Suzuki S, et al. A novel screening method for influenza patients using a newly developed non-contact screening system. J Infect 2010 Apr;60(4):271-7 [Abstract]
Matsushita M, Takeuchi S, Kumagai N, et al. Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population. Vaccine 2011 (published online Dec 15) [Abstract]
Matsuzaki Y, Katsushima N, Nagai Y, et al. Clinical features of influenza C virus infection in children. J Infect Dis 2006 May 1;193(9):1229-35 [Abstract]
Matsuzaki Y, Mizuta K, Aoki Y, et al. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virol J 2010 Mar 5;7:53 [Abstract]
Maurer J, Harris KM, Parker AM. Who knew? Awareness of being recommended for influenza vaccination among US adults. Influenza Other Respi Viruses 2011 (published online Nov 26) [Abstract]
Maurer J, Uscher-Pines L, Harris KM. Awareness of government seasonal and 2009 H1N1 influenza vaccination recommendations among targeted US adults: The role of provider interactions. Am J Infect Control 2010 Aug;38(6):489-90 [Abstract]
Maurer J, Uscher-Pines L, Harris KM. Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter? Prev Med 2010 Aug;51(2):185-7 [Abstract]
Maxwell SR. Tamiflu and neuropsychiatric disturbance in adolescents. BMJ 2007 Jun 16;334(7606):1232-3 [Extract]
McAuley JL, Chipuk JE, Boyd KL, et al. PB1-F2 proteins from H5N1 and 20th century pandemic influenza viruses cause immunopathology. PLoS Pathog 2010 Jul 22;6(7):e1001014 [Full text]
McBrayer A, Camp JV, Tapp R, et al. Course of seasonal A/Brisbane/59/07 H1N1 infection in the ferret. Virol J 2010 Jul 9;7:149 [Abstract]
McCullers JA, Hayden FG. Fatal influenza B infections: time to reexamine influenza research priorities. (Editorial) J Infect Dis 2012 (published online Jan 30) [Abstract]
McCullers JA, McAuley JL, Browall S, et al. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 2010 Oct 15;202(8):1287-95 [Abstract]
McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007 Dec 15;45(12):1568-75 [Abstract]
McGeer A, Lee W, Loeb M, et al. Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults. Infect Control Hosp Epidemiol 2004 Dec;25(11):955-61 [Abstract]
McLennan S, Wicker S. Reflections on the influenza vaccination of healthcare workers. Vaccine 2010 Nov 29;28(51):8061-4 [Abstract]
McMahon AW, Iskander JK, Haber P, et al. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine 2008 Jan 17;26(3):427-9 [Abstract]
McNeil SA, Dodds LA, Fell DB, et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S54-7 [Abstract]
McNeil SA, Noya F, Dionne M, et al. Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults. Vaccine 2007 Apr 30;25(17):3464-74 [Abstract]
McQuillan L, Daley MF, Stokley S, et al. Impact of the 2004-2005 influenza vaccine shortage on pediatric practice: a national survey. Pediatrics 2009 Feb;123(2):e186-92 [Abstract]
Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science 2009 Sep 25;325(5948):1705-8 [Abstract]
Mehle A, Doudna JA. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci 2009 Dec 15;106(50):21312-6 [Abstract]
Mehlmann, M, Bonner AB, Williams JV, et al. Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza. J Clin Microbiol 2007 Apr;45(4):1234-7 [Abstract]
Meijer A, Falcao JM, Jong JC, et al. Clinical influenza activity in Europe is still low, with influenza B virus being dominant: an update from EISS. Eurosurveillance Weekly 2006 Feb 16;11(2):pii=2899 [Full text]
Meijer A, Lackenby A, Hay A, et al. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. Eurosurveillance Monthly 2007 Apr;12(4):pii=698 [Full text]
Meijer A, Lackenby A, Hungnes O, et al. Oseltamivir-resistant influenza A (H1N1) virus, Europe, 2007-08 season. Emerg Infect Dis 2009 Apr;15(4):552-60 [Full text]
Meijer A, Meerhoff TJ, Meuwissen LE, et al. Epidemiological and virological assessment of influenza activity in Europe during the winter 2005-2006. Eurosurveillance Monthly 2007 Sep;12(9):1209-226 [Full text]
Meijer A, Meerhoff TJ, Meuwissen LE, et al. Very little influenza activity in Europe up until the end of 2005. Eurosurveillance Weekly 2006 Jan 6;11(1):pii=2869 [Full text]
Meijer A, Paget WJ, Meerhoff TJ, et al. Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winter. Eurosurveillance Monthly 2006 May;11(5):pii=623 [Full text]
Meisner J, Szretter KJ, Bradley KC, et al. Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice. J Virol 2008 May;82(10):5079-83 [Abstract]
Melen K, Kinnunen L, Fagerlund R, et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 2007 Jun;81(11):5995-6006 [Abstract]
Melendi GA, Laham FR, Monsalvo AC, et al. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics 2007 Aug;120(2):e410-5 [Abstract]
Melidou A, Kyriazopoulou V, Diza E, et al. Antiviral resistance of influenza A(H3N2) strains isolated in Northern Greece between 2004 and 2007. Eurosurveill 2009 Jan 29;14(4):pii=19104 [Full text]
Memoli MJ, Jagger BW, Dugan VG, et al. Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift. J Infect Dis 2009 Oct 15;200(8):1232-41 [Abstract]
Menon B, Gurnani M, Aggarwal B. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination. Int J Clin Pract 2008 Apr;62(4):593-8 [Abstract]
Mereckiene J, Cotter S, D'Ancona, et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill 2010 Nov 4;15(44):pii=19700 [Full text]
Mereckiene J, Cotter S, Nicoll A, et al. National seasonal influenza vaccination survey in Europe, 2008. Eurosurveill 2008 Oct 23;13(43):2 [Full text]
Mereckiene J, Cotter S, Weber JT, et al. Low coverage of seasonal influenza vaccination in the elderly in many European countries. Eurosurveill 2008 Oct 9;13(41):1 [Full text]
Metzgar D, Myers CA, Russell KL, et al. Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants. PLoS One 2010 Feb 3;5(2):e8995 [Full text]
Meyerholz DK, Edsen-Moore M, McGill J, et al. Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol 2008 Jul 1;181(1):641-8 [Abstract]
Mibayashi M, Martinez-Sobrido L, Loo YM, et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007 Jan;81(2):514-24 [Abstract]
Michiels B, Govaerts F, Remmen R, et al. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine 2011 Nov 15;29(49):9159-70 [Abstract]
Michiels B, Philips H, Coenen S, et al. The effect of giving influenza vaccination to general practitioners: a controlled trial. BMC Med 2006 Jul 10;4:17 [Abstract]
Milkman KL, Beshears J, Choi JJ, et al. Using implementation intentions prompts to enhance influenza vaccination rates. Proc Natl Acad Sci 2011 (published online Jun 13) [Abstract]
Miller B, Kassenborg H, Dunsmuir W, et al. Syndromic surveillance for influenzalike illness in ambulatory care setting. Emerg Infect Dis 2004 Oct;10(10):1806-11 [Full text]
Miller BL, Ahmed F, Lindley MC, et al. Increases in vaccination coverage of healthcare personnel following institutional requirements for influenza vaccination: a national survey of US hospital. Vaccine 2011 Nov 21;29(50):9398-403 [Abstract]
Miller BL, Ahmed F, Lindley MC, et al. Institutional requirements for influenza vaccination of healthcare personnel: results from a nationally representative survey of acute care hospitals--United States, 2011. Clin Infect Dis 2011 Dec 1;53(11):1051-9 [Abstract]
Miller EK, Dumitrescu L, Cupp C, et al. Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age. Vaccine 2011 Apr 18;29(18):3431-7 [Abstract]
Miller EK, Griffin MR, Edwards KM, et al. Influenza burden for children with asthma. Pediatrics 2008 Jan;121(1):1-8 [Abstract]
Miller HB, Gose RB, Nagata MT, et al. Pacific region influenza surveillance for oseltamivir resistance. J Clin Virol 2012 (published online Jan 30) [Abstract]
Min JY, Vogel L, Matsuoka Y, et al. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J Virol 2010 Nov;84(22):11950-60 [Abstract]
Minor DS, Eubanks JT, Butler KR, et al. Improving influenza vaccination rates by targeting individuals not seeking early seasonal vaccination. Am J Med 2010 Nov;123(11):1031-5 [Full text]
Minor PD. Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production. Clin Infect Dis 2010 Feb 15;50(4):560-5 [Abstract]
Miotto O, Heiny AT, Albrecht R, et al. Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One 2010 Feb 3;5(2):e9025 [Full text]
Mishin VP, Hayden FG, Gubareva LV. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 2005 Nov;49(11):4515-20 [Abstract]
Misplon JA, Lo CY, Gabbard JD, et al. Genetic control of immune responses to influenza A matrix 2 protein (M2). Vaccine 2010 Aug 16;28(36):5817-27 [Abstract]
Mohamed AG, BinSaeed AA, Al-Habib H, et al. Communicability of H1N1 and seasonal influenza among household contacts of cases in large families. Influenza Other Respi Viruses 2011 (published online Nov 26) [Abstract]
Mok CK, Lee DC, Cheung CY, et al. Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol 2007 Apr;88(4):1275-80 [Abstract]
Monto AS, McKimm-Breschkin JL, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006 Jul 1;50(7):2395-402 [Abstract]
Monto AS, Ohmit SE, Petrie JG, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009 Sep 24;361(13):1260-7 [Full text]
Monto AS, Ohmit SE. Seasonal influenza vaccines: evolutions and future trends. (Perspective) Expert Rev Vaccines 2009 Apr;8(4):383-9 [Abstract]
Monto AS, Rotthoff J, Teich E, et al. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis 2004 Aug 15;39(4):459-64 [Abstract]
Monto AS, Whitley RJ. Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clin Infect Dis 2008 Apr 1;46(7):1024-31 [Abstract]
Monto AS. Seasonal influenza and vaccination coverage. Vaccine 2010 Aug 14;28(suppl 4):D33-44 [Abstract]
Monto AS. Seasonal influenza vaccinations: specialized products for different target groups. Vaccine 2010 Aug 14;28(suppl 4):D14-23 [Abstract]
Monto AS. The role of antivirals in the control of influenza. Vaccine 2003 May 1;21(16):1796-800 [Abstract]
Moody MA, Zhang R, Walter EB, et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS ONE 2011 Oct 19;6(10):e25797 [Full text]
Mook P, Ellis J, Watson JM, et al. Public health implication of influenza B outbreaks in closed settings in the United Kingdom in the 2007/08 influenza season. Eurosurveillance 2008 Sep 18;13(38):pii=18986 [Full text]
Moore K, Black J, Rowe S, et al. Syndromic surveillance for influenza in two hospital emergency departments: relationships between ICD-10 codes and notified cases, before and during a pandemic. BMC Public Health 2011 May 18;11:338 [Abstract]
Morelon E, Noble CP, Daoud S, et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 2010 Oct 4;28(42):6885-90 [Abstract]
Morens DM, Burke DS, Halstead SB. The wages of original antigenic sin. (Commentary) Emerg Infect Dis 2010 Jun;16(6):1023-4 [Full text]
Morens DM, Taubenberger JK. Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respi Viruses 2010 Nov;4(6):327-37 [Abstract]
Moro PL, Broder K, Zheteyeva Y, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the vaccine adverse event reporting system, 1990-2009. Am J Obstet Gynecol 2011 Feb;204(2):146 [Abstract]
Moscona A, McKimm-Breschkin J. News about influenza B drug resistance that cannot be ignored. (Editorial) JAMA 2007 Apr 4;297(13):1492-3 [Extract]
Moscona A. Global transmission of oseltamivir-resistant influenza. (Perspective) N Engl J Med 2009 Mar 5;360(10):953-6 [Full text]
Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005 Sep 29;353(13):1363-73 [Extract]
Moscona A. Oseltamivir-resistant influenza? (Commentary) Lancet 2004;364(9436):733-4 [Full text]
Moss R, McCaw JM, McVernon J, et al. Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic. PLoS ONE 2011 Feb 4;6(2):e14505 [Full text]
Mota NVVP, Lobo RD, Toscano CM, et al. Cost-effectiveness of sick leave policies for health care workers with influenza-like illness, Brazil, 2009. Emerg Infect Dis 2011 Aug;17(8):1421-9 [Full text]
Mubareka S, Palese P. Human genes and influenza. J Infect Dis 2008 Jan 1;197(1):1-3 [Full text]
Mubareka SM, Lowen AC, Steel J, et al. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis 2009 Mar 15;199(6):858-65 [Abstract]
Mueller MR, Smith PJ, Baumbach JP, et al. Influenza testing and antiviral prescribing practices among emergency department clinicians in 9 states during the 2006 to 2007 influenza season. Ann Emerg Med 2010 Jan;55(1):32-9 [Abstract]
Muller D, Szucs TD. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 2007 Oct;35(5):308-19 [Abstract]
Muller MP, McGeer AJ, Hassan K, et al. Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza. PLoS ONE 2010 Mar 5;5(3):e9563 [Full text]
Mullooly JP, Bridges CB, Thompson WW, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007 Jan 15;25(5):846-55 [Abstract]
Murata Y, Walsh EE, Falsey AR. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis 2007 Apr 1;195(7):1029-37 [Abstract]
Murcia PR, Baillie GJ, Daly J, et al. Intra- and interhost evolutionary dynamics of equine influenza virus. J Virol 2010 Jul;84(14):6943-54 [Abstract]
Murcia PR, Wood JLN, Holmes EC. Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus. J Virol 2011 Jun;85(11):5312-22 [Abstract]
Mutsch M, Tavernini M, Marx A, et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005 May 1;40(9):1282-7 [Abstract]
Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004 Feb 26;350(9):896-903 [Abstract]
Myers AL, Lantos J, Douville L, et al. Healthcare worker knowledge and attitudes regarding influenza immunization and childhood vaccination. Clin Infect Dis 2010 Jun;31(6):643-6 [Abstract]
Myers CA, Kasper MR, Yasuda CY, et al. Dual infection of novel influenza viruses A/H1N1 and A/H3N2 in a cluster of Cambodian patients. Am J Trop Med Hyg 2011 Nov;85(5):961-3 [Abstract]
Myers ER, Misurski DA, Swamy GK. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy. Am J Obstet Gynecol 2011 Jun;204(6):S128-40 [Abstract]
NACCHO. Public health use and distribution of antivirals: NACCHO think tank meeting report. Released Jan 28, 2011 (but dated Dec 2010) [Full text]
Nachamkin I, Shadomy SV, Moran AP, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barre syndrome. J Infect Dis 2008 Jul 15;198(2):226-33 [Abstract]
Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011 Dec 3;378(9807):1917-30 [Abstract]
Nakamura MM, Lee GM. Influenza vaccination in adolescents with high-risk conditions. Pediatrics 2008 Nov;122(5):920-8 [Abstract]
Nakowitsch S, Wolschek M, Morokutti A, et al. Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N1 intranasal influenza vaccine candidates lacking NS1. Vaccine 2011 Apr 27;29(19):3517-24 [Abstract]
Navas E, Salleras L, Dominguez A, et al. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine 2007 Apr 20;25(16):3233-9 [Abstract]
Negri E, Colombo C, Giordano L, et al. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005 Apr 22;23(22):2851-61 [Abstract]
Neirynck S, Deroo T, Saelens X, et al. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999 Oct;5(10):1157-63 [Abstract]
Nelson CA, France EK, Shetterly SM, et al. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection. Pediatr Infect Dis J 2011 Jul;30(7):562-5 [Abstract]
Nelson MI, Edelman L, Spiro D, et al. Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog 2008 Aug;4(8):e1000133 [Full text]
Nelson MI, Holmes EC. The evolution of epidemic influenza. Nature Rev Genet 2007 Mar;8(3):196-205 [Abstract]
Nelson MI, Lemey P, Tan Y, et al. Spatial dynamics of human-origin H1 influenza A virus in North American swine. PLoS Pathog 2011 Jun 9;7(6):e1002077 [Full text]
Nelson MI, Simonsen L, Viboud C, et al. Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog 2007 Sep;3(9):e131 [Full text]
Nelson MI, Simonsen L, Viboud C, et al. Stochastic processes are key determinants of short-term evolution in influenza A virus. PLoS Pathogens 2006 Dec;2(12):e125 [Full text]
Nelson MI, Viboud C, Simonsen L, et al. Multiple reassortant events in the evolutionary history of H1N1 influenza A virus since 1918. PLos Pathog 2008 Feb 29;4(2):e1000012 [Full text]
Nelson NP, Brownstein JS, Hartley DM, et al. Event-based biosurveillance of respiratory disease in Mexico, 2007-2009: connection to the 2009 influenza A(H1N1) pandemic? Euro Surveill 2010 Jul 29;15(30):pii=19626 [Full text]
Neuzil KM, Bright RA. Influenza vaccine manufacture: keeping up with change. (Editorial) J Infect Dis 2009 Sep 15;200(6):835-7 [Full text]
Neuzil KM, Dupont WD, Wright PF, et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001;20(8):733-40 [Abstract]
Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006 Oct 15;194(8):1032-9 [Abstract]
NFID (National Foundation for Infectious Diseases). Improving influenza vaccination rates in health care workers: strategies to increase protection for workers and patients. 2004 [Full text]
Ng S, Cowling BJ, Fang VF, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 2010 Mar 1;50(5):707-14 [Abstract]
Ng S, Wu P, Nishiura H, et al. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11. BMC Infect Dis 2011 Aug 26;11:230 [Abstract]
Ng WC, Wong V, Muller B, et al. Prevention and treatment of influenza with hyperimmune bovine colostrum antibody. PLoS ONE 2010 Oct 26;5(10):e13622 [Full text]
Ngaosuwankul N, Noisumdaeng P, Komolsiri P, et al. Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses. Virol J 2010 Apr 20;7:75 [Abstract]
Nguyen JT, Hoopes JD, Le MH, et al. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS One 2010 Feb 22;5(2):e9332 [Full text]
Nguyen JT, Hoopes JD, Smee DF, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 2009 Oct;53(10):4115-26 [Abstract]
NICE (UK National Institute for Health and Clinical Excellence). Influenza (prophylaxis): amantadine, oseltamivir and zanamivir. Sep 24, 2008 [Full text of several guidance documents]
Nichol KL, D'Heilly S, Ehlinger E. Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use. Clin Infect Dis 2005 May 1;40(9):1263-70 [Abstract]
Nichol KL, D'Heilly SJ, Greenberg ME, et al. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. Clin Infect Dis 2009 Feb 1;48(3):292-8 [Full text]
Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007 Oct 4;357(14):1373-81 [Full text]
Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S111-8 [Abstract]
Nichol KL. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine 2011 Oct 6;29(43):7554-8 [Abstract]
Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008 Sep 12;26(suppl 4):D17-22 [Full text]
Nicholls JM, Bourne AJ, Chen H, et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 2007 Oct 25;8:73 [Abstract]
Nichols WG, Guthrie KA, Corey L, et al. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004 Nov 1;39(9):1300-6 [Abstract]
Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003 Nov 22;362(9397):1733-45 [Abstract]
Nicoll A, Ciancio B, Kramarz on behalf of the Influenza Project Team. Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications. (Editorial) Eurosurveillance Weekly 2008 Jan 31;13(5):pii=8025 [Full text]
Nicoll A, Ciancio BC, Tsolova S, et al. The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Eurosurveill 2008 Oct 23;13(43):pii=19018 [Full text]
Nielsen J, Mazick A, Glismann S, et al. Excess mortality related to seasonal influenza and extreme temperatures in Denmark, 1994-2010. BMC Infect Dis 2011 Dec 16;11:350 [Abstract]
Nilsson AC, Alemo B, Bjorkman P, et al. Around-the-clock, rapid diagnosis of influenza by means of membrane chromatography antigen testing confirmed by polymerase chain reaction. Infect Control Hosp Epidemiol 2008 Feb;29(2):177-9 [Abstract]
Ninove L, Gazin C, Gould EA, et al. A simple method for molecular detection of swine-origin and human-origin influenza A virus. Vector-Borne Zoonotic Dis 2010 Apr;10(3):237-40 [Full text]
Njabo KY, Fuller TL, Chasar A, et al. Pandemic A/H1N1/2009 influenza virus in swine, Cameroon, 2010. Vet Microbiol 2011 (published online Sep 12) [Abstract]
Noda T, Sagara H, Yen A, et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 2006 Jan 26;439(7075):490-2 [Abstract]
Nokleby H, Nicoll A. Risk groups and other target groups: preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010-11. Euro Surveill 2010 Mar 25;15(12):pii=19525 [Full text]
Nolan T, Bernstein DI, Block SL, et al. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics 2008 Mar;121(3):508-16 [Abstract]
Nosyk B, Sharif B, Sun H, et al. The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus. PLoS ONE 2011 Dec 6;6(12):e27059 [Full text]
Nowalk MP, Lin CJ, Zimmerman RK, et al. Self-reported influenza vaccination rates among health care workers in a large health system. Am J Infect Control 2008 Oct;36(8):574-81 [Abstract]
Nunes B, Viboud C, Machado A, et al. Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS ONE 2011 Jun 21;6(6):e20661 [Full text]
O'Donnell CD, Subbarao K. The contribution of animals models to the understanding of the host-range and virulence of influenza A viruses. Microbes Infect 2011 May;13(5):502-15 [Abstract]
Obayashi E, Yoshida H, Kawai F, et al. The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature 2008 Aug 28;454(7208):1127-31 [Abstract]
Ofstead CL, Tucker SJ, Beebe TJ, et al. Influenza vaccination among registered nurses: information receipt, knowledge, and decision-making at an institution with a multifaceted educational program. Infect Control Hosp Epidemiol 2008 Feb;29(2):99-106 [Abstract]
Ogata N, Shibata T. Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection. J Gen Virol 2008 Jan;89(1):60-7 [Abstract]
Ohmit SE, Monto AS Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis 2006 Sep 1;43(5):564-8 [Abstract]
Ohmit SE, Petrie JG, Cross RT, et al. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis 2011 (published online Oct 12) [Abstract]
Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006 Dec 14;355(24):2513-22 [Full text]
Ohmit SE, Victor JC, Teich ER, et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008 Aug 1;198(3):312-7 [Abstract]
Ohshima N, Iba Y, Kubota-Koketsu R, et al. Naturally occurring antibodies in a human can neutralize a broad spectrum of influenza strains including H3, H1, H2 and H5. J Virol 2011 Nov;85(21):11048-57 [Abstract]
Olson DR, Heffernan RT, Paladini M, et al. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Medicine 2007 Aug;4(8):e247 [Full text]
Omer SB, Goodman D, Steinhoff MC, et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011 May 31;8(5):e100441 [Full text]
Ong AK, Chen MI, Lin L, et al. Improving the clinical diagnosis of influenza--a comparative analysis of new influenza A (H1N1) cases. PLoS One 2009 Dec 29;4(12):e8453 [Full text]
Ong AK, Hayden FG. John F. Enders lecture 2006: antivirals for influenza. J Infect Dis 2007 Jul 15;196(2):181-90 [Abstract]
Opstelten W, van Essen GA, Ballieux MJP, et al. Influenza immunization of Dutch general practitioners: vaccination rate and attitudes towards vaccination. Vaccine 2008 Nov 5;26(47):5918-21 [Abstract]
Opstelten W, van Essen GA, Heijnen ML, et al. High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice. Vaccine 2010 Aug 31;28(38):6164-8 [Abstract]
Ortiz JR, Englund JA, Neuzil KM. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 2011 Jun 15;29(27):4439-52 [Abstract]
Ortiz JR, Neuzil KM. The promise of maternal vaccination to prevent influenza in young infants. (Editorial) Arch Pediatr Adolesc Med 2011 Feb;165(2):179-80 [Abstract]
Ortiz JR, Sotomayor V, Uez OC, et al. Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis 2009 Aug;15(8):1271-8 [Full text]
Ortiz JR, Zhou H, Shay DK, et al. Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends. PLoS ONE 2011 Apr 27;6(4):e18687 [Full text]
Osterhaus A, Fouchier R, Rimmelzwaan G. Towards universal influenza vaccines? (Commentary) Philos Trans R Soc Lond B Biol Sci 2011 Oct 12;366(1579):2766-73 [Abstract]
Osterhaus ADME, Poland GA (eds). Influenza vaccines: research, development and public health challenges. Vaccine 2008 Sep 12;26(suppl 4):D1-174 [Abstract]
Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012 Jan;12(1):36-44 [Abstract]
Ostovar GA, Kohn N, Yu KOA, et al. Nosocomial influenza in a pediatric hospital: comparison of rates of seasonal and pandemic 2009 influenza A/H1N1 infection. Infect Control Hosp Epidemiol 2012 (published online Jan 6) [Abstract]
Otsuka T, Fujinaka H, Katsuyama K, et al. Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season. Vaccine 2007 Jun 6;25(23):4521-24 [Abstract]
Ottenberg AL, Wu JT, Poland GA, et al. Vaccinating health care workers against influenza: the ethical and legal rationale for a mandate. (Commentary) Am J Public Health 2011 Feb;101(2):212-6 [Abstract]
Ozawa M, Fujii K, Muramoto Y, et al. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol 2007 Jan;81(1):30-41 [Abstract]
Ozawa M, Goto H, Horimoto T, et al. An adenovirus vector-mediated reverse genetics system for influenza A virus generation. J Virol 2007 Sep;81(17):9556-9 [Abstract]
Pabbaraju K, Ho KCY, Wong S, et al. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007). Antiviral Res 2008 Aug;79(2):81-6 [Abstract]
Paddock CD, Liu L, Denison AM, et al. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis 2012 (published online Jan 30) [Abstract]
Paget J, Marquet R, Meijer A, et al. Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (aspreada) across Europe. BMC Infect Dis 2007 Nov 30;7:141 [Full text]
Paget WJ, Meijer A, Falcao JM, et al. Seasonal influenza activity for 2005-2006 season seems to be ending in most European countries. Eurosurveillance Weekly 2006 Apr 13;11(4):pii=2940 [Full text]
Palache A. Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies. Vaccine 2011 Nov 28;29(51):9459-66 [Abstract]
Palacios G, Quan P-L, Jabado OJ, et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 2007;13(1):73-81 [Full text]
Palamara AT, Nencioni L, Aquilano K, et al. Inhibition of influenza A virus replication by resveratrol. J Infect Dis 2005 May 15;191(10):1719-29 [Abstract]
Palese P, Wang TT. Why do influenza virus subtypes die out? a hypothesis. (Commentary) mBio 2011 Aug 30;2(5):e00150-11 [Abstract]
Palese P. Making better influenza virus vaccines. Emerg Infect Dis 2006 Jan;12(1):61-5 [Full text]
Palmer LA, Rousculp MD, Johnston SS, et al. Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: the child and household influenza-illness and employee function (CHIEF) study. Vaccine 2010 Jul 12;28(31):5049-56 [Abstract]
Paltrinieri S, Spagnolo V, Giordano A, et al. Influenza virus type A serosurvey in cats. (Letter) Emerg Infect Dis 2007 Apr;13(4):662-4 [Full text]
Pan K. Understanding original antigenic sin in influenza with a dynamical system. PLoS ONE 2011 Aug 29;6(8):e23910 [Full text]
Pano-Pardo JR, Martinez-Sanchez N, Martin-Quiros A, et al. Influenza-like illness in pregnant women during summertime: clinical, epidemiological and microbiological features. Eur J Clin Microbiol Infect Dis 2011 Dec;30(12):1497-502 [Abstract]
Pariani E, Amendola A, Zappa A, et al. Molecular characterization of influenza viruses circulating in Northern Italy during two seasons (2005/2006 and 2006/2007) of low influenza activity. J Med Virol 2008 Nov;80(11):1984-91 [Abstract]
Pariani E, Boschini A, Amendola A, et al. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. Vaccine 2011 Nov 15;29(49):9209-13 [Abstract]
Park AW, Daly JM, Lewis NS, et al. Quantifying the impact of immune escape on transmission dynamics of influenza. Science 2009 Oct 30;326(5953):726-8 [Abstract]
Parkins MD, Fonseca K, Peets AD, et al. A potentially preventable case of serious influenza infection in a pregnant patient. CMAJ 2007 Oct 9;177(8):851-3 [Full text]
Parry MF, Grant B, Iton A, et al. Vaccination: A collaborative effort to improve the health of the community. Infect Control Hosp Epidemiol 2004 Nov;25(11):929-32 [Abstract]
Partridge J, Kieny MP, World Health Organization H1N1 Influenza Vaccine Task Force. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 2010 Jul 5;28(30):4709-12 [Abstract]
Paterson B, Caddis R, Durrheim D. Use of workplace absenteeism surveillance data for outbreak detection. (Letter) Emerg Infect Dis 2011 Oct;17(10):1963-4 [Full text]
Paton NI, Lee L, Xu Y, et al. Chloroquine for influenza prevention: a randomized, double-blind, placebo controlled trial. Lancet Infect Dis 2011 Sep;11(9):677-83 [Abstract]
Peacey M, Hall RJ, Sonnberg S, et al. Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009. Emerg Infect Dis 2010 Oct;16(10):1618-20 [Full text]
Pearson ML, Bridges CB, Harper SA, et al. Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR 2006 Feb 9;55(Early release):1-16 [Full text]
Pearton M, Kang SM, Song JM, et al. Changes in human langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS ONE 2010 Aug 25;5(8):e12410 [Full text]
Pebody R, Andrews N, Waight P, et al. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 2011 Mar 21;29(14):2613-8 [Abstract]
Pebody R, Hardelid P, Fleming DM, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill 2011 Feb 10;16(6):pii=19791 [Full text]
Pechirra P, Goncalves P, Arraiolos A, et al. Characterization of influenza A/Fujian/411/2002(H3N2)-like viruses isolated in Portugal between 2003 and 2005. J Med Virol 2008 Sep;80(9):1624-30 [Abstract]
Pelat C, Falchi A, Carrat F, et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS ONE 2011 May 10;6(5):e19621 [Full text]
Peltola V, Reunanen T, Ziegler T, et al. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005 Oct 15;41(8):1190-200 [Abstract]
Perdue ML, Bright RA. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world. Vaccine 2011 Jul 1;29(suppl 1):A48-50 [Abstract]
Perera RAPM, Riley S, Ma SK, et al. Seroconversion to pandemic (H1N1) 2009 virus and cross-reactive immunity to other swine influenza viruses. Emerg Infect Dis 2011 Oct;17(10):1897-9 [Full text]
Perez JT, Varble A, Sachidanandam R, et al. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci 2010 Jun 22;107(25):11525-30 [Abstract]
Perez-Ruiz M, Yeste R, Ruiz-Perez MJ, et al. Testing of diagnostic methods for detection of influenza virus for optimal performance in the context of an influenza surveillance network. J Clin Microbiol 2007 Sep;45(9):3109-110 [Abstract]
Petousis-Harris H, Poole T, Booy R, et al. Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under. Vaccine 2011 Apr 5;29(16):2933-7 [Abstract]
Petric M, Comanor L, Petti CA. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 2006 Nov 1;194(suppl 2):S98-110 [Abstract]
Petrie JG, Ohmit SE, Johnson E, et al. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011 May;203(9):1309-15 [Abstract]
Pfeil A, Mutsch M, Hatz C, et al. A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations. BMC Public Health 2010 Jul 7;10:402 [Abstract]
Phillips AC, Gallagher S, Carroll D, et al. Preliminary evidence that morning vaccination is associated with an enhanced antibody response in men. Psychophysiology 2008 Jul;45(4):663-6 [Abstract]
Pica N, Chou YY, Bouvier NM, et al. Transmission of influenza B viruses in the guinea pig. J Virol 2012 (published online Feb 1) [Abstract]
Pica N, Hai R, Krammer F, et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci 2012 (published online Jan 30) [Abstract]
Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005 Feb 18;23(13):1540-8 [Abstract]
Piedra PA, Gaglani MJ, Kozinetz CA, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007 Sep;120(3):e553-64 [Abstract]
Pinsky BA, Mix S, Rowe J, et al. Long-term shedding of influenza A virus in stool of immunocompromised child. Emerg Infect Dis 2010 Jul;16(7):1165-7 [Full text]
Pinto CA, Bozkurt I. Rapid sensor technology: a risk and system complexity analyses of early detection of influenza-like-illnesses. J Homeland Secur Emerg Manage 2009;6(1) (published online Dec 16) [Abstract]
Pitt T, Kalicinsky C, Warrington R, et al. Assessment of epicutaneous testing of a monovalent influenza A (H1N1) 2009 vaccine in egg allergic patients. Allergy Asthma Clin Immunol 2011 Feb 11;7:3 [Abstract]
Podewils LJ, Liedtke LA, McDonald LC, et al. A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis 2005 Jun 1;40(11):1693-6 [Abstract]
Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006 Jul 6;355(1):31-40 [Abstract]
Poehling KA, Fairbrother G, Zhu Y, et al. Practice and child characteristics associated with influenza vaccine uptake in young children. Pediatrics 2010 Oct;126(4):665-73 [Abstract]
Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011 Jun;204(6 suppl):S141-8 [Abstract]
Poland GA, Jacobson RM, Ovsyannikova IG. Influenza virus resistance to antiviral agents: a plea for rational use. (Commentary) Clin Infect Dis 2009 May 1;48(9):1254-6 [Full text]
Poland GA, Morse D. Improving the public health: the U.S. recommendation for universal influenza immunization. (Editorial) Vaccine 2010 Apr 1;28(16):2799-800 [Full text]
Poland GA, Ofstead CL, Tucker SJ, et al. Receptivity to mandatory influenza vaccination policies for healthcare workers among registered nurses working on inpatient units. Infect Control Hosp Epidemiol 2008 Feb;29(2):170-3 [Abstract]
Poland GA. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010 Sep 7;28(4):D3-13 [Abstract]
Polgreen PM, Chen Y, Pennock DM, et al. Using Internet searches for influenza surveillance. Clin Infect Dis 2008 Dec 1;47(11):1443-8 [Abstract]
Polgreen PM, Nelson FD, Neumann GR. Use of prediction markets to forecast infectious disease activity. Clin Infect Dis 2007 Jan 15;44(2):272-9 [Abstract]
Polgreen PM, Polgreen LA, Evans T, et al. A statewide system for improving influenza vaccination rates in hospital employees. Infect Control Hosp Epidemiol 2009 May;30(5):474-8 [Abstract]
Polgreen PM, Septimus E, Talbot TR, et al. Results of a national survey of infectious diseases specialists regarding influenza vaccination programs for healthcare workers. Infect Control Hosp Epidemiol 2010 Oct;31(10):1063-5 [Abstract]
Polgreen PM, Tassier TL, Pemmaraju SV, et al. Prioritizing healthcare worker vaccinations on the basis of social network analysis. Infect Control Hosp Epidemiol 2010 Sep;31(9):893-900 [Abstract]
Polgreen PM, Yang M, Bohnett LC, et al. A time-series analysis of Clostridium difficile and its seasonal association with influenza. Infect Control Hosp Epidemiol 2010 Apr;31(4):382-7 [Abstract]
Polisena J, Chen Y, Manuel D. The proportion of influenza vaccination in Ontario, Canada in 2007/2008 compared with other provinces. Vaccine 2012 (published online Jan 13) [Abstract]
Polkinghorne BG, Muscatello DJ, MacIntyre CR, et al. Relationship between the population incidence of febrile convulsions in young children in Sydney, Australia and seasonal epidemics of influenza and respiratory syncytial virus, 2003-2010: a time series analysis. BMC Infect Dis 2011 Oct 26;11:291 [Abstract]
Price CS, Thompson WW, Goodson B, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 2010 Oct;126(4):656-64 [Abstract]
Price GE, Soboleski MR, Lo CY, et al. Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses. PLoS ONE 2010 Oct 4;5(10):e13162 [Full text]
Priest PC, Duncan AR, Jennings LC, et al. Thermal image scanning for influenza border screening: results of an airport screening study. PLoS ONE 2011 Jan 5;6(1):e14490 [Full text]
Principi N, Esposito S, Gasparini R, et al. Flu-Flu Study Group. Burden of influenza in healthy children and their households. Arch Dis Child 2004 Nov: 89(11):1002-7 [Abstract]
Principi N, Esposito S, Marchisio P, et al. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 2003;22(10 Suppl):S207-10 [Abstract]
Principi N, Esposito S. Are we ready for universal influenza vaccination in paediatrics? Lancet Infect Dis 2004 Feb 1; 4(2):75-83 [Abstract]
Principi N, Esposito S. Pediatric influenza prevention and control. Emerg Infect Dis 2004 Apr;10(4):574-80 [Full text]
Proff R, Gershman K, Lezotte D, et al. Case-based surveillance of influenza hospitalizations during 2004 -2008, Colorado, USA. Emerg Infect Dis 2009 Jun;15(6):892-8 [Full text]
Prosser LA, Meltzer MI, Fiore A, et al. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years. Arch Pediatr Adolesc Med 2011 Feb;165(2):112-8 [Abstract]
Puig-Barbera J, Arnedo-Pena A, Pardo-Serrano F, et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain: a test-negative, hospital-based, case-control study. Vaccine 2010 Nov 3;28(7):7460-7 [Abstract]
Puig-Barbera J, Diez-Domingo J, Varea AB, et al. Effectiveness of MF59(TM)-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007 Oct 16;25(42):7313-21 [Abstract]
Puig-Barbera J. 2010-2011 influenza seasonal vaccine, preliminary mid-season effectiveness estimates: reason for concern, confounding or are we following the right track? (Editorial) Euro Surveill 2011 Mar 17;16(11):pii=19821 [Full text]
Puzelli S, Facchini M, Di Martino A, et al. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic. Antiviral Res 2011 Apr 14;90(3):205-212 [Abstract]
Quan FS, Compans RW, Kang SM. Oral vaccination with inactivated influenza vaccine induces cross-protective immunity. Vaccine 2012 Jan 5;30(2):180-8 [Abstract]
Quan FS, Compans RW, Nguyen HH, et al. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol 2008 Feb;82(3):1350-9 [Abstract]
Quan FS, Kim YC, Vunnava A, et al. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol 2010 Aug;84(15):7760-9 [Abstract]
Quan FS, Steinhauer D, Huang C, et al. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine 2008 Jun 19;26(26):3352-51 [Abstract]
Quan FS, Yoo DG, Song JM, et al. Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J Virol 2009 May;83(9):4489-97 [Abstract]
Quan PL, Palacios G, Jabado OJ, et al. Detection of respiratory viruses and subtype identification of influenza A viruses by Gree
| 
